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In this study we have established a method for screening a collection of strains, from 
the Bacillus cereus group of bacteria, for biofilm formation, including soil isolates, strains 
from culture collections, reference strains, dairy isolates, and clinical strains from different 
types of human infections. Certain strains from the B. cereus group, which includes the 
opportunistic human pathogen B. cereus, insecticidal B. thuringiensis, and the obligate human 
and animal pathogen B. anthracis, are known to have the ability to form biofilm, an attached 
state in which cells are closely packed and firmly attached to each other and usually a solid 
surface. In biofilm, microorganisms aggregate and excrete a protective and adhesive matrix of 
a polymeric, usually carbohydrate-containing, substance. The matrix may provide beneficial 
functions, such as protection from antibiotics and the immune system during infection and 
giving bacterial cells the ability to communicate during growth. Biofilm formation is known, 
at least for certain bacterial pathogens, to contribute to the aetiology of human disease, 
exemplified by Pseudomonas aeruginosa infections in cystic fibrosis patients. 
In this study 81 strains have been screened for biofilm formation, resulting in the 
confirmation of 7 strains, which form biofilm. The ability to form biofilm has not been 
observed to specifically correlate with strain origin; however strains isolated outside their 
natural environment (soil and insect intestine) have shown a higher propensity to form 
biofilm.  
  
We have also initiated gene disruption studies in a candidate regulatory gene, the 
pleiotropic transcriptional regulator plcR, to reveal its possible involvement in biofilm 
formation in Bacillus cereus ATCC 10987, a strain closely related to B. anthracis, isolated 
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1.1 The Bacillus genus 
The Bacillus genus consist of gram-positive, facultative anaerobic, spore-forming, rod 
shaped, motile bacteria commonly found in soil and insect intestine, but also in dairy product, 
food and some species may cause infection in humans and animals. The vegetative cells range 
from 0.5 by 1.2 to 2.5 by 10 μm in diameter (Turnbull et al., 1991). The genus is highly 
heterogeneous, certain species are psychrophilic or thermophilic, but optimal growth is seen 
in the temperature range between 25ºC and 37ºC. The G+C content of the DNA can vary from 
32% to 69% between different species, and most strains are catalase positive, possess 
peritrichous flagella, and sporulate in air (Turnbull et al., 1991; Turnbull et al., 1990). 
 
1.2 The Bacillus cereus group of bacteria 
The Bacillus cereus group of bacteria, a cluster within the Bacillus genus, comprises 
six recognized species, namely Bacillus anthracis, Bacillus cereus, Bacillus mycoides, 
Bacillus pseudomycoides, Bacillus thuringiensis and Bacillus weihenstephanensis (Gordon et 
al., 1973; Lechner et al., 1998; Priest et al., 1988; Turnbull et al., 1991). A close genetic 
relationship has been observed between all members and it is therefore suggested that the 
entire group represents a single species (Helgason et al., 2000; Patra et al., 2002). DNA 
sequence variations in the 16S-23S internally transcribed spacers (Daffonchio et al., 2000), 
Multilocus Enzyme Electrophoresis (MLEE) (Helgason et al., 2000) and sequence analysis of 
house-keeping genes (Helgason et al., 2002) suggest that B. anthracis, B. cereus sensu stricto 
and B. thuringensis are members of a single species, B. cereus sensu lato.  Characteristics 
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have been suggested to allow the differentiation and identification of the B. cereus group 
members (Drobniewski et al., 1993; Granum et al., 2001) and the key diagnostic feature used 
for identification of B. cereus strains, until now, has been their ability to provoke haemolysis 
and to hydrolyze lecithin, but an inability to ferment mannitol. This media-based-
identification method is still the most commonly used method for identification of B. cereus 
(Holbrook et al., 1980).  
The B. cereus group bacteria, compared to other Bacilli group bacteria, are a group of 
bacteria, which carry a high amount of pathogenicity genes. The genes encoding for the 
pathogenicity in B. anthracis against mammals (including humans) and the pathogenicity in 
B. thuringensis against insects are coded for and present on plasmids. The presences of these 
plasmids are used as a method for differentiation of species within the B. cereus group. B. 
cereus is also seen to carry large plasmids, but their involvement in pathogenicity is still 
unclear. Emetic B. cereus does, however, carry emetic toxin genes on large plasmids, 
indicating that the plasmids do in all cases both define the sub species of the B. cereus group 
of bacteria and contribute to the pathogenicity of the strain. 
 
1.2.1 Bacillus anthracis 
Bacillus anthracis is the causative agent of anthrax, which is primarily a disease in 
mammals, including man (Mock and Fouet, 2001). Anthrax had been linked to endemic soil 
environments long before B. anthracis was identified as the causative agent (Rayer et al., 
1850; Davaine et al., 1863). Virulence of B. anthracis is based on the presence of the two 
virulence plasmids, pXO1 (181, 7 kbp) and pXO2 (94, 8 kbp), present in all virulent strains. 
The plasmid pXO1 encodes three toxic factors: the protective antigen (PA), the lethal factor 
(LF) and the oedema factor (EF) (Bhatnagar and Batra, 2001), while the pXO2 plasmid 
encodes a poly-D-glutamic acid capsule enabling the bacterium to resist complement binding 
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and phagocytosis after initial phagocytosis of spores and germination. Both plasmids have 
been sequenced and functional studies are currently under way (Okinaka et al., 1999 a and b). 
Models, available, of B. anthracis ecology, rely on its pathogenicity, i.e. how the spores are 
ingested by herbivores, how the animals become infected and how the bacteria proliferate in 
the lymphoid glands, expressing the exotoxins, which ultimately leads to the death of the 
animal (Figure 1.1). Once the animal is dead the bacteria will again form spores, a process 
directly linked to depletion of nutrients and presence of oxygen, and have an unknown fate in 
the environment (Jensen et al., 2003). 
 
 
Figure 1.1: Hypothetical model in which the members of the B. cereus group experience two life cycles: one 
type (left figure) in which the bacteria live in a symbiotic relation with their invertebrate host(s) and another 
(right figure), more infrequent life cycle, in which the bacteria can multiply rapidly in another infected insect 
host or a mammal, from Jensen et al., 2003.
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1.2.2 Bacillus thuringensis 
Bacillus thuringensis is generally regarded as an insect pathogen, because of its ability 
to produce large crystal protein inclusions (δ-endotoxins) during sporulation. These δ-
endotoxins are seen to be encoded mainly on the plasmids as so-called cry-genes (Kronstad et 
al., 1983; Gonzàlez and Carlton, 1984), where they are actively synthesised. As much as 20% 
of the proteins synthesised during sporulation are products of the cry-genes and result in 
depositions as intracellular, crystalline inclusions. Upon completion of sporulation and mother 
cell lyses, the spore and inclusions are released, and the inclusions and spores are able to be 
ingested by insects, resulting in the protoxin solubilising in the alkaline midgut and there be 
converted to toxins (Aronson, 2002). The toxin will be able to bind to the mid-gut epithelial 
cells, creating pores in the cell membrane. As a result, the gut is rapidly immobilized and the 
epithelial cells lyse. This is considered the only feature that can distinguish B. thuringensis 
from B. cereus (Baumann et al., 1984). These inclusions, which constitute up to 25% of the 
dry weight of the sporulated cells (Agaisse and Lerecluse, 1995), are responsible for the 
biopesticide activity of the bacterium and its target specificity (van Rie et al., 1990). The 
insecticidal spectrum varies within the 83 different serotypes reported (Lecadet et al., 1999), 
and affects insects primarily from the orders Lepidoptera, Diptera and Coleoptera. There are 
also reports of B. thuringensis isolates active against mosquitoes, which are vectors for 
diseases such as malaria and yellow fever (Orduz et al., 1995). According to Martin and 
Travers (1989), B. thuringensis is a ubiquitous soil microorganism, but it is also found in 
environmental niches, including phylloplane and insects. The bacteria have until now also 
been found in water mills, in corn crops and in mosquito breeding habitats (Vankova and 
Purrini, 1979; Porcar and Caballero, 2000; Damgaard, 2000). Other findings have shown that 
the ecological niches occupied by B. thuringensis are several; i) B. thuringensis does not 
originate from soil, but is deposited there by insects (Glare and O´Callaghan, 2000); ii) B. 
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thuringensis may grow in soil only when the nutrient conditions are correct (Saleh et al., 
1970); iii) B. thuringensis occupies the same niche as B. cereus and iv) vegetative B. 
thuringensis proliferates in the gut of the earthworm, leather jacket larvae and in plant 
rhizospheres (Hendriksen and Hansen, 2002). These different possibilities are not mutually 
exclusive. It is conceivable that B. thuringensis is a natural inhabitant of the intestinal system 
of certain insects, with or without provoking disease and eventually death (Figure 1.1). 
Therefore, the bacterium is able to be released in the soil and subsequently to proliferate when 
conditions are naturally favourable. B. thuringensis is speculated to be a natural inhabitant of 
the digestion system of many invertebrates (Hansen and Salamitou, 2000) and can sporulate 
when nutrients become limited. 
 
1.2.3 Bacillus cereus 
Bacillus cereus is more or less ubiquitous in nature and an opportunistic pathogen. B. 
cereus was first recognized to be the causative agent of food-borne illness in the 1950’s. The 
diarrhoeal type of illness was described following the consumption of highly contaminated 
vanilla sauce; Hauge isolated B. cereus from the vanilla sauce and consumed it. After 16 
hours this resulted in abdominal pain, nausea and watery diarrhoea (Hauge, 1955). This led to 
the linking of B. cereus to diarrhoeal diseases and to a greater understanding of this group of 
bacteria. In recent years B. cereus has been recognized as a causative agent of gastrointestinal 
and nongastrointestinal diseases (Ehling-Sculz et al., 2004 and references therein). Two types 
of gastrointestinal diseases caused by B. cereus can be distinguished: emetic and diarrhoeal. 
The diarrhoeal type, caused by heat-labile enterotoxins, is mainly associated with meat 
products, vegetables and milk products, whereas emetic outbreaks, associated with a smaller 
heat-stable peptide toxin, are mainly linked to carbohydrate rich sources, such as rice, noodles 
and pasta (Shinagawa et al., 1990; Kramer et al., 1989). The emetic syndrome is mainly 
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characterized by vomiting 0.5 – 6 hours after ingestion of the contaminated food, while in the 
diarrhoeal syndrome symptoms appear 8 – 16 hours after ingestion and include abdominal 
pain and diarrhoea. Both types of food-borne illness are relatively mild and usually do not last 
more than 24 hours. Nevertheless, more severe cases have occasionally been reported and 
deaths have been registered due to ingestion of food contaminated with a high amount of 
emetic toxin (Lund et al., 2000; Mahler et al., 1997). B. cereus has also been shown to be 
responsible for wound and eye infections, systemic infections and may be linked to 
periodontitis (Beecher et al., 2000; Drobniewski et al., 1993; Helgason et al., 2000), and 
recently B. cereus has been identified as the cause of a series of serious or even life-
threatening infections in neutropenic and immunosuppressed patients and premature neonates 
(Arnaout et al., 1999; Hilliard et al., 2003). Its natural niche is probably the gut micro flora of 
invertebrates, but colonisation of mosquito larvae and various soil-dwelling pests have also 




Figure 1.2: An illustration of the known pathogenic life cycles of B. anthracis and B. thuringiensis. Although a 
human pathogen, B. cereus has not been shown to enter a pathogenic life cycle similar to those of B. anthracis 
and B. thuringiensis, from Jensen et al., 2003. 
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1.2.4 Bacillus mycoides/Bacillus pseudomycoides 
 Bacillus mycoides is distinguished from other members of the Bacillus cereus group 
by its rhizoid colony shape, made by curving filaments of bacterial cells and its lack of 
motility (Priest, 1993). Bacillus pseudomycoides is very similar to B. mycoides, however it 
does not have the long filaments of bacterial cells, hence the name pseudes. B. 
pseudomycoides is distinguished from B. mycoides and B. cereus by difference in cell 
membrane fatty acid contents (Nakamura, 1998). 
 
1.2.5 Bacillus weihenstephanensis 
 Bacillus weihenstephanensis is capable of growth below 7ºC and shows characteristic 
differences in specific cold-shock-genes compared to B. cereus (Lechner et al., 1998). 
However, there does also exist psychrotolerant strains of the B. cereus group, which not 
necessary are B. weihenstephanensis (Stenfors & Granum, 2001). It is not known if B. 
weihenstephanensis strains are capable of causing food poisoning as is the case with B. 
cereus, but the genetic composition of essential pathogenicity factors are seen to be present 
and thought to be expressed (Stenfors et al., 2002), such as non-haemolytic enterotoxin Nhe.   
. 
1.2.6 Bacillus cereus group and genetics 
Like many other bacteria, research on the Bacillus cereus group has benefited from the 
genomic revolution that started in 1995 with the publication of the first microbial genome 
sequence, that of Haemophilus influenzae (Fleischmann et al., 1995). This has allowed for 
further research into the genetics, proteomics and transcriptomics of this group of bacteria. To 
date, the genome sequences of 15 isolates from the B. cereus group of bacteria are available in 
public databases and more are underway (www.genomesonline.org). Consequently, this group 
of bacteria provides one of the richest collections of near neighbour sequences, which will 
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impact future efforts due to the large amounts of data available for comparison between 
strains and genes. The B. anthracis A2012 strain (Florida strain), isolated from the victim of 
the bio terrorism attack in Florida (Pearson et al., 2004), was the first draft genome to be 
published followed by the complete genome of B. anthracis Ames (Read et al., 2003), and to 
date 10 B. anthracis strains have been sequenced (www.genomesonline.org). B. cereus ATCC 
14579 was selected for whole genome sequencing as it is non-pathogenic and is the Type 
strain for B. cereus (Ivanova et al., 2003; Sneath et al., 1986). Whole-genome-based 
phylogenetic analysis done using B. anthracis Ames, B. cereus ATCC 14579 and B. cereus 
ATCC 10987, a dairy isolate, showed that B. cereus ATCC 10987 was phylogenetic more 
closely related to B. anthracis Ames than to B. cereus ATCC 14579 (Rasko et al., 2004). 
While the genome sequence of B. cereus ATCC 14579 revealed a small extra chromosomal 
linear molecule (Ivanova et al., 2003), B. cereus ATCC 10987 contained a large circular 
plasmid with homology to the B. anthracis plasmid pXO1 (Rasko et al., 2004).  
The isolates for which whole genome sequences are now available, do not properly 
represent the diversity observed in the B. cereus group of bacteria through methods such as 
Multilocus Sequence Typing (MLST; Helgason et al., 2005) and Multilocus Enzyme 
Electrophoresis (MLEE; Helgason et al., 2000). The choice of strains for sequencing up till 
now reflects bias driven by the need to understand rare pathogenic traits in some of these 
species (Rasko et al., 2005). Only the future will, through new sequencing projects, allow an 
entire picture of this group of bacteria to form. 
 
1.2.7 Sporulation 
The Bacillus cereus group bacteria possess several complex development programs 
that drive environmental adaptation and morphological differentiation. These changes are 
seen to be quite elaborate and can result in major changes in cell appearance (Driks, 2002). 
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One of the best studied of these systems is spore formation, which is a characteristic feature in 
Bacilli and is well characterised in Bacillus subtilis. The spore is entirely distinct from the 
vegetative cell, possessing several molecules and structures unique to the spore (Kornberg et 
al., 1968; Murell, 1967; Murrell, 1969 and Warth et al., 1963), such as the molecules SpoA 
and σ-factors and structures as additional polysaccharides in the outer wall. Actively growing 
Bacilli are induced to differentiate into spores by starvation of carbon, nitrogen or, in some 
circumstances a phosphorus source, and spore formation is seen to take 7 hours at 37ºC 
(Piggot et al., 2004). Since B. subtilis is the best described spore forming Gram-positive 
bacterium, most genes related to spore formation are designated from B. subtilis, i.e. initiation 
signals resulting in activation of the master transcription regulator, Spo0A, which activates 
and triggers asymmetric sporulation division and transcription of the spoIIA, spoIIE and 
spoIIG loci, which all encode for development regulators. This will result in the initiation and 
activation of sigma factors required for sequential mother cell and forespore gene 
transcription (Errington, 1993; Driks, 1999). These genes are also present in the B. cereus 
group bacteria, as identical or partially identical genes, and will presumably drive the same 
activation process and transcriptional control (Aronson, 2002).  Sporulation division produces 
two distinct cells with different fates, the smaller prespore (forespore), which develops into 
the spore, and the mother cell, which will ultimately lyse and die. The surviving spore is able 
to survive for a long period of time, endure high temperatures, disinfection, UV-radiation and 
chemicals, and inhospitable environments such as soil and the ocean (Priest, 1993; Francis et 
al., 1999), but can also sense the reappearance of even minute amounts of nutrients in the 
environment, and respond by converting back to a vegetative growing cell (Atrih et al., 1999), 
in a separate developmental process called germination. Sporulation, used by Bacilli and 
many other Gram-positive bacteria, is seen as not only a way for survival, but also as a 
strategy for pathogenesis as the spore in many cases act as the infectious agent. 
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1.3 Biofilm formation 
Microorganisms are often viewed as simple creatures when compared with other, more 
complex organisms, however studies of microbial development have shown that 
microorganisms are capable of complex differentiation and behaviour (O’Toole et al., 2000). 
Examples include Bacillus spore formation, in which individual vegetative cells integrate 
multiple external and internal signals to successfully synthesize a new morphological 
structure that allows it to adapt for survival in a variety of harsh environments (1.2.7). 
Another excellent model system for study is the formation of surface-attached microbial 
communities, known as biofilms. Biofilms can be defined as communities of microorganisms 
that are attached to a surface. These communities consist of multiple layers of cells usually 
embedded in hydrated matrices of polysaccharides, either comprising single or multiple 
microbial species and can form on a range of biotic and abiotic surfaces. Although mixed-
species biofilms predominate in most environments, such as teeth and gut, single-species 
biofilms exist in a large variety of infections, on surface of medical implants and on surfaces 
connected to the food industry (Adal et al., 1996; Archibald et al., 1997; Dickinson et al., 
1993). These single-species biofilms are the focus of most current research, which include 
gram-negative biofilm-forming bacteria Pseudomonas aeruginosa (O’Toole et al., 2000), 
Escherichia coli and Vibrio cholerae (Yildiz et al., 1999) and gram-positive biofilm-forming 
bacteria Staphylococcus epidermidis (Heilmann et al., 1998), Staphylococcus aureus, Bacillus 
lichienformis (Ameur et al., 2000), Bacillus subtilis (Branda et al., 2004) and Bacillus cereus 
(1.4).  
Biofilms are a stable point in a biological cycle that includes initiation, maturation, 
maintenance and dissolution (Figure 1.3). Bacteria seem to initiate biofilm development in 
response to specific environmental conditions, such as nutrient availability and/or the lack of 
it or the presence of other bacteria in the surrounding environment. Many examples indicate 
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that development of biofilms requires multicellular behavior and that the development of a 
biofilm is a complex process that requires collective bacterial behavior, many times involving 
more than one species. 
 
 
Figure 1.3: Model of biofilm development. Individual planktonic cells can form cell-to-surface and cell-to-cell 
contacts resulting in the formation of microcolonies and mature biofilms. Cells in the biofilm can return to a 
planktonic lifestyle to complete the cycle of biofilm development, from O’Toole et al., 2000. 
  
Prokaryotes can inhabit any environment suitable for higher life forms, as well as a 
variety of inhospitable settings that the majority of higher life forms find extreme (Madigan et 
al., 1997). The one key element seen to affect biofilm formation is the ability of the bacteria 
to position themselves in niches where they can propagate. The common mechanisms for 
biofilm formation include flagellar based motility and different methods of surface 
translocation; e.g. twitching, gliding, darting and sliding motility (Henrichsen et al., 1972). 
Bacterial communities in nature play a key role in the production and degradation of organic 
matter, which requires the combined effort of many species of bacteria with different 
metabolic capabilities, and are only able to perform this “expected” role in a community of 
several bacteria, often of different species. Bacteria are also thought to experience a certain 
degree of shelter and homeostasis when residing within a biofilm and one of the key 
components of this micro niche is the surrounding extrapolymeric substance matrix. This 
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matrix is often composed of a mixture of components, such as extracellular polysaccharides 
(EPS), proteins, nucleic acids, and many other substances present in the environment of 
biofilm formation. Bacteria are capable of producing polysaccharides themselves, either as 
wall polysaccharides (capsule) or as extracellular excretions into the surrounding environment 
(EPS in S. aureus, E. coli, V. cholerae and P. aeruginosa). EPS most likely play various roles 
in the structure and function of different biofilm communities and EPS may also play 
different roles in similar microbial communities under different environmental conditions 
(Dahlberg et al., 1997; Watnick et al., 1999; Yildiz et al., 1999). The EPS matrix also has the 
potential to physically prevent access of certain antimicrobial agents into the biofilm by acting 
as an ion exchanger and thereby restricting diffusion of compounds from the surroundings 
into the biofilm (Gilbert et al., 1997). The level of potential prevention, by the EPS matrix 
from antimicrobial agents, is totally dependant on the type, amount and properties 
(hydrophobicity and charge) of the antimicrobial agent in circulation. Furthermore, EPS can 
provide protection from a wide variety of environmental stress factors, such as UV radiation, 
pH shifts, osmotic shock and desiccation (Flemming, 1993).  
 Biofilms have been seen to have highly permeable water channels interspersed 
throughout the biofilm, and these have been compared to primitive circulation systems. They 
provide an effective means of exchange of nutrients and metabolites as well as removal of 
potentially toxic metabolites (Costerton et al., 1995). The elaborate architecture provides the 
opportunity for metabolic cooperation and consequently provides for the improved growth 
and survival of most biofilms. 
 One of the greatest advances in modern medicine has been the fight against infectious 
diseases. There are, however, exceptions to this rule. The fight against bacteria, that form 
biofilm, is still not completely won. Bacteria in biofilm can be seen to be up to 1000-fold 
more resistant to antibiotic treatment than the same organism grown planktonically (Gilbert et 
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al., 1997) and survival rates are much higher in biofilm forming bacteria. Biofilm forming 
bacterial infections are more difficult to fight due to several elements such as, antibiotic 
resistance, protection from stress factors, the high recurrence frequency and the fact that 
biofilm infections are rarely resolved by the host’s immune system. P. aeruginosa in patients 
with cystic fibrosis, chronic ear infections and periodontitis are examples of infections caused 
by biofilm forming bacteria seen to be difficult to combat and cure.  
Biofilms do seem to play a role in adhesion to surfaces, both biotic and abiotic, and 
subsequently colonization of surfaces (O’Toole et al., 2000). This is thought to be due to the 
higher levels of adhesion molecules present when cells group and the cooperation between 
cells growing in biofilm. Cell-surface interactions have been seen to be the initiating factor in 
biofilm formation (Heilmann et al., 1996; Heilmann et al., 1998). These interactions may be 
mediated through a number of factors, including uncharacterized surface proteins (Hussain et 
al., 1997), extracellular proteins (Schumacher-Perdreau et al., 1994), capsular 
polysaccharide/adhesion molecules on the surface of the bacteria (McKenney et al., 1998) and 
cell surface-localized autolysins (Heilmann et al., 1997), which aid in the movement of 
bacteria on a surface by making the surface smoother. The subsequent phase is the so-called 
“accumulative phase”, which involves cell-cell interactions and the formation of cell 
aggregates on the surface. Numerous studies have been done to implicate polysaccharide 
intercellular adhesion (PIA) molecules in this process, but conclusive studies are still not 
done. The last stage of biofilm formation is the maturation of the bacterial community. This 
involves the production of extracellular polysaccharides (“slime”) when the bacteria are 
growing on a surface. Little is known about how this extracellular polysaccharide affects the 
normal development of the biofilm and what role it plays in determining its architecture. 
Detachment of bacterial cells from the biofilm is seen after biofilm formation, but very little is 
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known about this and it is not a given that all biofilm forming bacteria, are able to detach, or 
how this process is mediated. 
Biofilm formation does initiate a large amount of gene regulation, which is evident 
from the fact that organisms have multiple genetic pathways that control biofilm behavior 
(O’Toole et al., 2000). Up-regulation of genes has been seen to occur during biofilm 
formation, such as the up-regulation of adhesion molecule genes in V. cholerae and up-
regulation of pili-mediated movement in P. aeruginosa. Down-regulation, however, of 
specific genes in biofilm forming bacteria has been difficult to confirm, but is thought to 
happen (O’Toole et al., 2000). The growth rate of bacteria in process of forming biofilm and 
when biofilm is formed is seen to be elevated compared to the growth rate during planktonic 
growth, but genetic background information is scarce and up-regulation of growth may only 
be the result of the general up-regulation of genes during biofilm formation. 
  
1.4 Bacillus cereus and biofilm formation  
 Different Bacillus species (B. subtilis, B. cereus and B. thuringensis) are known to 
form biofilm on solid surfaces and at air-liquid interfaces, often depending on environmental 
conditions. In the natural environments of the Bacillus species, biofilm formation may be the 
first step in a complex developmental process that simultaneously or sequentially incorporates 
fruiting body formation (Branda et al., 2001), sporulation (Stragier and Losick, 1996), natural 
competence (Busch and Saier, 2002; Dubnau, 1999; Solomon and Grossman, 1996; Saier, 
2000), planktonic motile cell release (Sauer et al., 2004) and cell raft swarming (Julkowska et 
al., 2004/2005).  
B. cereus can easily contaminate food production or processing systems (Kotiranta et 
al., 2000) and some strains have the ability to form biofilms that are highly resistant to 
cleaning products (Peng et al., 2002). Biofilm formation occurs in a manner similar to the 
 14
found in better characterized B. subtilis; however biofilm forming B. cereus are mostly seen 
in the food and milk industry. Further speculations have been made as to where B. cereus has 
the ability to form biofilm, on/between teeth, in surgical wound and in milk tanks, but no 
large scale study has been done. Some Bacillus species, isolated from alkaline wash solutions 
used for cleaning in dairy factories, were shown to attach to stainless steel surfaces and 
produce proteases and lipases (Lindsay et al., 2000), and thought to be a source of post-
pasteurization contamination of milk and milk products. Through proteomic investigation of 
dairy-associated B. cereus biofilm (Oosthuizen et al., 2001; Oosthuizen et al., 2002) and 
comparison of two-dimensional gel electrophoresis of proteins found in different states of 
growth, several potential genes involved in biofilm formation within B. cereus strains have 
been identified. However, these results have not given any definite indications of genes 
involved with biofilm formation. 
  
1.5 Screening for biofilm formation 
 A concerted effort to study microbial biofilms began only 20 years ago with the 
rediscovery that, in natural aquatic systems, bacteria are found predominantly attached to 
surfaces (Geesey et al., 1977). Although biofilm formation has been recognized and has been 
a scientifically documented aspect of microbial physiology for more than 100 years, the 
understanding of the molecular process is just underway. During the past years simple 
screening, of isolates of biofilm defective mutants, has been made possible, thus making 
genetic analysis of biofilm development possible (Heilmann et al., 1996; Mack et al., 1994).  
A simple screening method has been implemented utilizing plastic (PVC or 
polystyrene) 96-well microtiter dishes as a substrate for biofilm development, allowing large-
scale screening of bacterial strains for the ability to form biofilm. Biofilm formation is often 
visualized by staining cells attached to the surface with a variety of dyes (such as crystal 
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violet or safranin) followed with washing and solubilisation of cells. Many bacterial dyes are 
positively charged (cationic) and combine with negatively charged cellular components such 
as nucleic acids (DNA and RNA) and acidic polysaccharides. Methylene blue, crystal violet 
and safranin are such cationic dyes. Other bacterial dyes are negatively charged (anionic) and 
combine with positively charged cellular components, such as proteins. Eosin and acid 
fuchsin are anionic dyes. The simplicity of this screening method has made possible the 
screening of thousands of randomly generated mutants, giving an indication of the genetic 
background for biofilm formation. B. cereus has been shown to form biofilm more frequently 
on PVC 96-well microtiter plates instead of polystyrene, in fresh LB medium containing 
bactopeptone instead of tryptone, and to be ideally stained with crystal violet (Auger et al., 
2006). These findings have allowed the simultaneous screening of many B. cereus strains (this 
thesis; Michel Gohar, personal communication). 
 
1.6 Genetics of biofilm formation 
In Gram-negative bacteria known to form biofilm (E. coli, P. aeruginosa, P. 
fluorescens and V. cholerae), defects in genes involved in flagellar-mediated motility hinder 
biofilm formation under certain conditions; in E. coli, flagellar-mediated motility is important 
in establishing cell-surface contacts during biofilm formation in Luria Bertani (LB) broth 
(Pratt et al., 1998; Genevaux et al., 1996). Similarly, mutant non-motile strains of P. 
aeruginosa and P. fluorescens have been isolated in screens searching for defects in biofilm 
formation (O’Toole et al., 1998). Twitching motility, which refers to surface translocation 
mediated by type IV pili, appears to be widespread among Gram-negative bacteria (Wall et 
al., 1999) and has also been shown to be important for initial biofilm structural development 
by P. aeruginosa. It is important to note that even though these studies assign motility a major 
 16
role in biofilm formation, formation is also observed in strains without any known form of 
motility.  
Nutritional background can also be an important factor for biofilm formation, seen for 
instance by the ompR allele in E. coli, a member of the subfamily of response regulators that 
have fourteen homologues in E. coli alone (Mizuno, 1997). OmpR has been seen to aid the 
production of curli (type of fimbriae/pili) in non-motile strains by sensing low levels of 
nutrition and thereby allowing the formation of biofilm (Vidal et al., 1998). It is thought that 
force-generating movement helps to overcome overall repulsive forces between bacteria and 
surface, thereby increasing the chances of bacteria making the initial interaction with the 
surface. Once initial contact has been made, production of adhesion molecules are established 
by outer-membrane proteins. Overproduction of curli is thought to make non-motile E. coli 
“stickier”, allowing biofilm to form in the absence of force-generating movement.  
Essential attractive forces required for the establishment of stable interactions between 
bacteria and surfaces have been argued to be provided by specific outer-membrane proteins, 
such as genes encoding for the mannose-sensitive type I pilus, which are essential for E. coli 
biofilm formation in LB broth (Pratt et al., 1998). Type I pili are required for biofilm 
formation by E. coli on many surfaces, including PVC, and FimH, an element of Type I pili, 
has been observed to have the ability to bind both specifically and nonspecifically to mannose 
and abiotic surfaces. 
The potential role of extracellular factors in biofilm formation, have always been 
speculated to have an important role. In Gram-negative bacteria acylated homoserine lactones 
(acyl-HSLs), which are quorum-sensing signal molecules, have been demonstrated to be 
present both in aquatic biofilms grown on submerged stones (McLean et al., 1997), and in 
biofilms formed on urethral catheters (Stickler et al., 1998). The acyl-HSLs are synthesized 
and secreted in high levels in cultures in which cell density is high and are thought to have an 
 17
important role in late biofilm formation. Extracellular factors, such as Crc, can also have a 
sensing of the environment role. Crc plays a role, in P. aeruginosa, by sensing the availability 
of carbon sources, and has been shown to affect expression of the type IV pilA structural gene 
(O’Toole et al., 2000; MacGregor et al., 1991; Wolff et al., 1991). 
The story for Gram-positive bacteria, which are mostly non-motile, is different except 
for some motile species, such as B. cereus and B. subtilis.  In biofilm formation among Gram-
positive bacteria there is thought to be a more direct link between extracellular 
polysaccharides and adhesion to surfaces. In the Gram-positive bacterium B. subtilis, biofilm 
formation has been examined to some extent (Branda et al., 2001; Hamon and Lazazzera, 
2001), and several determinants of biofilm formation have been identified. Transcriptional 
regulators (AbrB, Spo0A, CcpA and σH), signal peptidase (SipW), and proteins involved in 
extracellular matrix synthesis (YveQ, YveR and YhxB) (Branda et al., 2004; Hamon and 
Lazazzera, 2001; Hamon et al., 2004; Stanley et al., 2003) are all required for biofilm 
formation. Recent results (Auger et al., 2006) show a clear connection between B. cereus 
biofilm formation and autoinducer 2 (AI-2) production. AI-2 was originally discovered in V. 
harveyi as a signal molecule and is thought to be a universal signaling factor for intra- and 
interspecies communication in response to cell density. In V. harveyi, AI-2 acts in conjunction 
with AI-1, an acyl-homoserine lactone signal, to regulate the luminescence in response to cell 
density, while in B. cereus it is thought to be a factor in sensing cell density during biofilm 
formation (Auger et al., 2006). 
 
1.7 The plcR regulon 
The PlcR transcriptional activator, originally discovered as a positive regulator 
involved in the expression of phosphatidylinositol-specific phospholipase C in B. thuringensis 
(Lereclus et al., 1996), is a global regulator controlling the expression of several non-specific 
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extracellular virulence factors in B. thuringensis. The B. thuringensis plcR gene is also present 
in B. cereus and B. anthracis and PlcR has also been seen to be a positive pleitropic regulator 
of several virulence factors in B. cereus (Agaisse et al., 1999; Økstad et al., 1999), but is non-
functional in B. anthracis. PlcR controls the expression of a large regulon comprising at least 
23 genes, which fall into three broad classes: (i) cell-surface proteins, (ii) degradative 
enzymes and (iii) toxins (Agaisse, et al., 1999; Gohar et al., 2002). Thus PlcR controls the 
transcription of several extracellular proteins, including phospholipases, proteases and 
haemolysins, in B. cereus and B. thuringiensis (Agaisse et al., 1999; Økstad et al., 1999). 
A nonsense mutation in the plcR gene has been shown to be responsible for the non-
haemolytic phenotype of B. anthracis (Agaisse et al., 1999). Recent reports have indicated 
that distinct mutations in plcR, which are observed in some B. cereus group strains, result in a 
haemolysis-negative and lecithinase-negative phenotype (Slamti et al., 2004). Mutations in 
the pleiotropic regulator PlcR thus might be a reason for some atypical characteristics when 
using the media-identification method (based on lecthinase-activity), and is also speculated to 
have a role in biofilm formation. Preliminary studies of the effect of PlcR on biofilm 
formation show that PlcR is expressed in biofilm forming cells of the strong biofilm former B. 
thuringensis 407, and that biofilm cells can excrete enterotoxins normally regulated by PlcR 
(Michel Gohar, personal communication). Furthermore, for another biofilm forming strain, B. 
cereus ATCC 10987, the culture supernatant has been shown to be able to confer biofilm 
formation properties to strains that are otherwise not able to form biofilm in experimental 
conditions (Michel Gohar, personal communication). It would therefore be of interest to 
construct a plcR knock-out strain of B. cereus ATCC 10987, to investigate a possible role of 
PlcR in biofilm formation in this strain, and the possible effect on the ability to induce biofilm 
formation in non-biofilm formers. 
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1.8 Bacillus cereus ATCC 10987 
 Bacillus cereus ATCC 10987 was isolated from a study on cheese spoilage in Canada 
in 1930 (Smith, 1952; Herron, 1930) and has been used as a model strain in our group for 
many years. This strain had been observed to have all the characteristics of a B. cereus strain, 
but did also have unknown pathogenic properties enabling the strain to colonise cheese 
production facilities. Recent studies have also shown that this strain has the ability to form 
biofilm (Auger et al., 2006; this thesis) and to produce proteins, which may have an effect on 
surrounding cells.  
Initial genome research resulted in the production of a genome map from a B. cereus 
ATCC 10987 pUC18 plasmid DNA library (Figure 1.4; Økstad et al., 1999), which indicated 
important markers and genes in the genome, but whose identity was unknown. This resulted 
in the entire genome being sequenced (Rasko et al., 2004) and allowed for the further use of 
this strain in both phylogenetic and molecular studies.  
The genome of B. cereus ATCC 10987 has now been demonstrated, through sequence 
analysis, to contain the plcR locus and plcR regulated putative virulence factors such as 
phosphatidylinositol-specific phospholipase C (PI-PLC), phosphatidylcholine-preferring 
phospholipase C (PC-PLC), sphingomyelinase, non-haemolytic enterotoxin and proteases 
(Økstad et al., 1999; Lindbäck et al., 1999), and to also express a high level of phospholipase 
C. B. cereus ATCC 10987 contains a single large plasmid that is similar to the B. anthracis 
pXO1 plasmid and encodes a number of unique factors and conserved regulatory proteins 
(Rasko et al., 2004). Based on overall protein and nucleotide similarity, phylogeny and shared 
novel genes, B. cereus ATCC 10987 is more closely related to B. anthracis Ames (Read et al., 
2003) than it is to another dairy-isolated B. cereus strain, the type strain ATCC 14579.   
 All this combined makes B. cereus ATCC 10987 a very interesting and exciting strain 
to work with and research will be continued in the future.  
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 Figure 1.4: Genome map of Bacillus cereus ATCC 10987, N1-N11 indicating NotI fragments and A1-A6 
indicating Asd fragments. Restriction fragments are ordered according to size with lowest number corresponding 
to the largest fragment. From Økstad et al., 1999. 
 
1.9 Aim of the study 
The aim of this study was to establish a method for screening a collection of more than 
81 strains from the B. cereus group for biofilm formation, including soil isolates, strains from 
culture collections, reference strains, dairy isolates, and clinical strains from different types of 
human infections. The ability to form biofilms would then be compared with strain origin, to 
investigate the frequency of biofilm formation in the B. cereus group of bacterial pathogens, 
and whether the propensity to form biofilm could be correlated with the source of isolation or 
with the strain phylogeny. We also aimed to initiate gene disruption studies in a candidate 
regulatory gene, plcR, to reveal its possible involvement in biofilm formation in B. cereus 
ATCC 10987. 
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2 MATERIALS AND METHODS 
 
2.1 Materials 
2.1.1 Bacterial strains 
Table 2.1: Bacterial strains used for biofilm screening 
Strain     Origin 
AH 75  Bacillus cereus ATCC 10987 (dairy, cheese spoilage, Canada) 
AH 181  Bacillus cereus ATCC 10876 (B.c 569) (NRRL, Agriculture Research Service, Peoria, U.S.A.) 
AH 183  Bacillus cereus ATCC 14579 (dairy) 
AH 186  Bacillus cereus F4433/73 (diarrhoea, patient, Central Public Health Laboratory, London, U.K.) 
AH 187  Bacillus cereus F4810/72 (vomit, patient, Central Public Health Laboratory, London, U.K.) 
AH 188  Bacillus cereus F837/76 (Central Public Health Laboratory, London, U.K.) 
AH 189  Bacillus cereus F2038/78 (Central Public Health Laboratory, London, U.K.) 
AH 226  Bacillus cereus ATCC 4342 (dairy) 
AH 248  Bacillus thuringensis, subsp. kurstaki 4D1 
AH 249  Bacillus thuringensis, subsp. kurstaki 4D4 
AH 252  Bacillus thuringensis, subsp. kurstaki 4H2 
AH 257  Bacillus thuringensis, subsp. israelensis 4Q1 
AH 258  Bacillus thuringensis, subsp. israelensis 4Q5 
AH 259  Bacillus cereus 6A1 
AH 265  Bacillus thuringensis 4A4 
AH 338  Bacillus mycoides (soil) 
AH 401  Bacillus cereus 181 (dairy, Sweden) 
AH 404  Bacillus cereus 3048 (dairy, Valio, Finland) 
AH 405  Bacillus cereus 1230 (dairy, Nurmes, Norway) 
AH 407  Bacillus cereus 3122 (dairy, Valio, Finland) 
AH 513  Bacillus cereus s1-2 (soil, Moss, Norway) 
AH 535  Bacillus cereus s2-21 (soil, Moss, Norway) 
AH 543  Bacillus cereus s3-1 (soil, Moss, Norway) 
AH 546  Bacillus cereus s3-5 (soil, Moss, Norway) 
AH 560  Bacillus cereus s4-3 (soil, Moss, Norway) 
AH 580  Bacillus cereus s4-24 (soil, Moss, Norway) 
AH 584  Bacillus cereus s4-28 (soil, Moss, Norway) 
AH 588  Bacillus cereus s4-32 (soil, Moss, Norway) 
AH 595  Bacillus cereus vet-1 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 597  Bacillus cereus vet-3 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 599  Bacillus cereus vet-5 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 601  Bacillus cereus vet-8 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 603  Bacillus cereus vet-10 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 604  Bacillus cereus vet-11 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 605  Bacillus cereus vet-17 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 607  Bacillus cereus vet-59 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 608  Bacillus cereus vet-61 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 609  Bacillus cereus vet-68 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 611  Bacillus cereus vet-87 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 612  Bacillus cereus vet-131 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 613  Bacillus cereus vet-132 (dairy, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 623  Bacillus cereus (soil, Tromsø, Norway) 
AH 631  Bacillus cereus (soil, Tromsø, Norway) 
AH 648  Bacillus cereus (soil, Tromsø, Norway) 
AH 652  Bacillus cereus (soil, Tromsø, Norway) 
AH 656  Bacillus cereus (soil, Tromsø, Norway) 
AH 681  Bacillus cereus (soil, Tromsø, Norway) 
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Strain     Origin 
AH 691  Bacillus cereus (soil, Tromsø, Norway) 
AH 699  Bacillus subtilis 168 
AH 724  Bacillus cereus (urine, patient, Skien, Norway) 
AH 810  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 811  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 812  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 813  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 814  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 815  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 816  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 818  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 819  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 820  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 831  Bacillus cereus (periodontitis, patient, Faculty of Dentistry, University of Oslo, Oslo, Norway) 
AH 874  Bacillus cereus SIC (clinical, patient, U.S.A.) 
AH 884  Bacillus cereus (blood, patient, Rikshospitalet, Oslo, Norway) 
AH 892  Bacillus cereus (wound after insect bite, patient, Regional Hospital, Tromsø, Norway) 
AH 1031 Bacillus thuringensis 407 (soil, Paris, France) 
AH 1091 Bacillus cereus ATCC14579 (dairy, cured of linear 15kb-plasmid) 
AH 1123 Bacillus cereus 9823 (clinical, France) 
AH 1127 Bacillus cereus 9843 (clinical, France) 
AH 1129 Bacillus cereus Bc004 (clinical, post-traumatic endophtalmitis, Univ. Oklahoma, U.S.A.) 
AH 1134 Bacillus cereus Bc006 (clinical, post-traumatic endophtalmitis, Univ. Oklahoma, U.S.A.) 
AH 1143 Bacillus weihenstephanensis WSBC 10201 
AH 1146 Bacillus weihenstephanensis WSBC 10205 
AH 1248 Bacillus thuringensis subsp. konkukian str. 97-27 (leg wound infection, French soldier, Bosnia)  
AH 1270 Bacillus cereus 0001+31175 (cervix, patient, Landsspitali, Reykjavik, Iceland) 
AH 1271 Bacillus cereus 9903+02049 (secretary lamp, Landsspitali, Reykjavik, Iceland) 
AH 1273 Bacillus cereus 9708+03060 (blood, patient, Landsspitali, Reykjavik, Iceland) 
AH 1295 Bacillus cereus (veterinary, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 1297 Bacillus cereus (veterinary, Norwegian College of Veterinary Medicine, Oslo, Norway) 
AH 1353 Bacillus cereus (food poisoning, diarrhoeal outbreak, Larvik, Norway) 
AH 1363 Bacillus cereus ATCC14579 (dairy, ΔplcR mutant) 
AH 1369 Bacillus cereus 9901+17036 (amniotic fluid, patient, Landsspitali, Reykjavik, Iceland) 
 
 
Table 2.2: Bacterial strains used for making genetic construct  
Strain     Origin 
AH 617  Escherichia coli (containing pAT113 plasmid) 
AH 1337  Escherichia coli (containing pUC19/spc-cassette plasmid) 
AH 1352 Escherichia coli (containing pUC19 plasmid) 





2.1.2.1 Reagents and chemicals 
NR. 1 bacterial agar         Oxoid 
Acetone          J.T.Baker 
Agarose          Sigma 
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Ampicillin          Sigma 
Bactopeptone           Oxoid 
Boric acid          Sigma 
Crystal violet           Sigma 
EDTA           M&B 
Erythomycin          Sigma 
Ethidiumbromide          Sigma 
Ethanol          Arcus 
Hydrochloric acid          Prolab 
Isopropanol           Arcus 
KCl           Merck 
KH2PO4          Merck 
Methanol           Prolab 
NaCl           Merck 
Na-citrate          J.T.Baker 
Orange G           BDH 
Spectionmycin         Sigma 
Seakem-GTG          FMC 
Tris-base           Sigma 
Tryptone           Oxoid 
Yeast Extract           Oxoid 
 
2.1.2.2 Enzymes 
HincII            NEB 
SacI            NEB 
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SalI            NEB 
KpnI            NEB 
HindIII          NEB 
EcoRI           NEB 
Alkaline phosphatase (CIP)        NEB 
DynAzyme II DNA polymerase        Finnzymes 
 
2.1.2.3 Solutions 
10 x TBE (TRIS/Borate Buffer) 
108.0 g Tris Base 
55.0 g Boric acid 
9.3 g EDTA 
Dissolved in 950 ml distilled water. 
Volume adjusted to 1 l with water. Not autoclaved. Stored at room temperature. 
TE-buffer, pH 7.6 
10 ml 1M Tris-HCl pH 7.6 
2 ml 0.5M EDTA pH 8.0 
Volume adjusted to 1 l with water. Autoclaved. Stored at 4 °C. 
Orange mix 
20 g Ficoll 
0.25 g Orange G 
4 ml 0.5M EDTA 
Dissolved in 100 ml of distilled water, sterile filtered and stored at - 20ºC. 
50 x TAE (TRIS/acetat buffer) 
2.0 M Tris Base 
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1.0 M cons. acetic acid 
50 mM 0.5 M EDTA pH 8.0 
Dissolved in 1 l distilled water. Not autoclaved. Stored at room temperature. 
PBS, pH 7.4 
136.9 mM NaCl 
2.7 mM KCl 
10.1 mM Na2HPO4x2H20 
1.8 mM KH2PO4
Dissolved in 5 l distilled water. PH adjusted to 7.4 with approximately 5.8 M HCL. 
Autoclaved, stored at room temperature. 
 
2.1.2.4 Growth media 
LB medium 
10 g Tryptone 
5 g Yeast Extract 
10 g NaCl 
Dissolved in 950 ml of distilled water. pH adjusted to 7.0 with 5.8 M HCl and volume 
adjusted to 1 l with water. Autoclaved and stored at + 4ºC. 
Bactopeptone medium 
10 g Bactopeptone 
5 g Yeast Extract 
10 g NaCl 
Dissolved in 950 ml of distilled water. pH adjusted to 7.0 with 5.8 M HCl and volume 
adjusted to 1 l with water. Autoclaved and stored at + 4ºC. 
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LB agar plates 
10 g Tryptone 
5 g Yeast Extract 
10 g NaCl 
15.0 g NR. 1 bacterial agar 
Dissolved in 950 ml of distilled water. pH adjusted to 7.0 with 5.8 M HCl and volume 
adjusted to 1 l with water. Autoclaved, plated out at 20 ml per plate and stored at + 4ºC. 
 
All agar and broth preparations were prepared following manufacturers instructions. All 
media was sterilized by autoclaving at 0.35 kg cm-2 for 20 minutes at 121º C. 
 
2.2 Methods 
2.2.1 Growth of bacteria 
All strains used were picked from the strain collection held at the Department of 
Pharmaceutical Biosciences, University of Oslo, which contains more than 300 different 
Bacillus cereus group strains. These stock strains where originally produced by growing a 
single colony of each strain in LB medium over night (~16 hours) at 30ºC with shaking at 225 
rpm. Culture was then reinoculated in fresh medium, and grown aerobic to an optical density 
at 600nm of 0.6 (OD600 = 0.6). Cell suspension (0.8 ml) was then mixed with 0.2 ml 87% 
(w/v) glycerol and stored at -70ºC until use. Optical density was measured using an 
Eppendorf BioPhotometer, following manufacturer’s guidelines. 
 
2.2.2 Growth curves 
Stock strains were picked from single colonies and grown in 10 ml LB medium over 
night at 30ºC and with shaking at 225 rpm. Inoculation of over night cultures (100 μl of 
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overnight culture) into 10 ml fresh LB medium was performed to give cultures used in 
bacterial growth curve determination. At each time point 100 μl of culture was extracted and 
diluted with 900 μl pure LB medium in a 1 ml plastic cuvette. Measurements of the optical 
density of the culture were done at 600nm, using Eppendorf BioPhotometer and following 
manufactures guidelines. All growth experiments were preformed in 30 ml sterilin tubes, at 
30ºC and with shaking at 225 rpm. 
 
2.2.3 Biofilm screening method 
 Bacillus cereus group bacteria are seen to form biofilm at the air-liquid interface if 
biofilm forming abilities are present in isolate. Biofilm formation is also seen to be stronger 
on PVC surface and to form a multilayer of cells in bactopeptone medium. Staining with 
crystal violet (Figure 2.1) of cells is seen to be efficient due to the ability of crystal violet to 
bind to the membrane of the cells and colour the cells a dark blue/violet. The crystal violet 
molecules bind between the outer membrane molecules and become permanently attached to 
the cells until solubilised, which may result in cell destruction.  
Stock strains were grown and picked from single colonies, inoculated in 10 ml LB 
medium and grown over night. Inoculation of over night cultures (100 μl) into fresh 10 ml LB 
medium was performed to produce exponential growth phase culture. The precultures, in 
exponential growth phase, after 3 hours of growth, were diluted in 10 ml of fresh 
bactopeptone medium (2.1.2.4) and transferred to 96-well polyvinylchloride microtiter plates 
in two parallel plates. Culture (125 μl) was inoculated in each well. After growth for 24, 48 
and 71 hours of incubation at 30º C, the biofilm density was measured as follows: i) the 
microtiter plate wells were washed once with PBS (130 μl), ii) bound cells were stained with 
1% (w/v) crystal violet solution (130 μl) at room temperature for 20 min (Hamon et al., 2001; 
Michel Gohar, personal communication; Auger, et al., 2006). 
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Figure 2.1: Structure of crystal violet, from www.DoChem.com. 
 
iii) Wells were then washed three times with PBS (180 μl), and remaining crystal violet 
attached to cells was solubilised with acetone/ethanol mixture (1:4) (150 μl). The absorbance 
of the solubilised dye at 590 nm (Figure 2.2) was subsequently determined. Absorbance was 
measured in HTS 7000 Plus, Bio Assay Reader (Perkin Elmer) using Perkin Elmer HTSoft 
Wizard 2.0. 
 
Figure 2.2: Absorbance pattern of crystal violet dissolved in water, from Du et al., 1998. 
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 2.2.4 Crystal violet staining of serial dilution of bacteria 
 To be able to show the correspondence between amount of bacterial cells and crystal 
violet staining a serial dilution of a culture, grown for 5 hours at 30ºC and with shaking at 225 
rpm, was stained by crystal violet and absorbance at 590nm was measured: In short, 1ml of 
overnight culture was pelleted at 13000 rpm for 1 minute, and resuspended in 100 μl PBS. 
This dilution was used to prepare an x2 serial dilution to a final dilution of 1/32 and stained 
with 1% (w/v) crystal violet (100 μl) for 20 minutes at room temperature. Stained cells were 
washed three times with PBS (1 ml) and solubilised with acetone/ethanol (1:4) (100 μl) 
solution. Absorbance was then measured at 590nm (2.2.3).  
 
2.3 Genetic methods 
2.3.1 plcR locus sequence extraction and primer design for gene deletion 
 plcR locus sequence extraction was performed using programs available through 
EMBNET (www.uio.no/EMBNET) and primer design was performed using Primer3 software 
available on the internet (http://frodo.wi.mit.edu). plcR locus sequence extraction and primers 
design was performed to allow the amplification of fragments of the upstream and 
downstream regions of the plcR gene through PCR, for use in plcR knock-out construct 
construction (Section 3.1). 
  
2.3.2 Genomic DNA extraction 
An LB agar plate was inoculated with a stock strain (stored at -70ºC) and incubated 
aerobically over night at 30ºC. A single colony from this plate was resuspended in 10 ml LB 
medium in 30 ml tubes and incubated aerobically over night at 30ºC and shaking (225 rpm). 
Overnight culture (100 μl) was inoculated in 10 ml LB medium in 30 ml tubes and grown for 
3 hours at 30ºC and shaking (225 rpm). Genomic DNA was isolated from the culture using 
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the Qiagen Genomic DNA 100 tip kit, which uses alkaline based lyses of bacterial cell, 
extraction of DNA via column (Qiagen anion-exchange resin) under low-salt and pH 
conditions, removal of RNA, proteins, dyes and low-molecular-weight impurities by a 
medium-slat wash, elution in a high-salt buffer and concentration and desalted by isopropanol 
precipitation of DNA. Manufacturer’s guidelines were followed. 
 
2.3.3 Polymerase chain reaction (PCR) 
The development and amplification of synthetic DNA has been made possible by 
polymerase chain reaction (PCR), a reaction that can multiply DNA molecules by up to a 
billion fold in a test tube. PCR requires that nucleotide sequence of desired gene is known, 
due to the necessity of primers complementary to the sequence in the gene. PCR also requires 
the presence of the 4 nucleic acids, cytosine, thymine, adenine and guanine, a DNA 
polymerase and a DNA polymerase buffer. 
PCR reactions were performed using ~50 ng chromosomal DNA, 32 pmol of each 
primer, 0.2 mM of each dNTP and 2 U DynAzyme II DNA polymerase (Finnzymes) in 1 x 
Dynazyme reaction buffer, in a 50 μl reaction volume. Reaction mixture was performed on ice 
to hinder unspecific primer binding and primer dimerisation. All primers had a calculated 
optimal melting point of 57ºC. 
 
PCR reaction in each tube (total volume of 50 μl): 
5 μl dNTP-mix (2 mM each dNTP) 
5 μl DynAzyme II polymerase buffer (10x) 
1 μl DynAzyme II polymerase (Finnzymes) (2U/μl) 
1 μl primer 1 (20 μM stock) 
1 μl primer 2 (20 μM stock) 
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1 μl template DNA (~50 ng) 
MilliQ-water to 50 μl  
  
The reactions were carried out on a GeneAmp 2700 PCR machine 
(AppliedBiosystems) with an initial denaturation step at 94º C for 5 minutes, followed by 30 
cycles of 94º C for 1 minute, annealing at 57ºC for 1 minute and polymerisation at 72ºC for 1 
minute, finishing with a final extension step at 72ºC for 7 minutes.  
 
2.3.4 Agarose Gel Electrophoresis 
Agarose gel electrophoresis is used to separate DNA fragments according to their size, 
in a network-like gel structure and the migration is based on the uniform negative charge of 
DNA forcing the molecules towards the positive pole in an electric field. DNA fragments are 
loaded in wells in the agarose gel and run through an electric field from negative charge to 
positive charge. Visualisation of DNA fragments is possible by ethidium bromide addition to 
the gel and UV illumination. Ethidium bromide has the ability to bind in between the base 
pares of DNA molecules and fluoresce in UV light. Size determination of fragments run on 
gel is done by comparison with size marker lambda/BstE II (NEB). BstE II digest of lambda 
DNA yields 14 fragments suitable for use as molecular weight standards for agarose gel 
electrophoresis (Picture 2.1). The approximate mass of DNA in each of the bands is provided 
for approximating the mass of DNA in comparably intense samples of similar size. 
           Electrophoresis grade agarose at a concentration of 1% (w/v) in 1xTBE buffer was 
used for agarose gel electrophoresis, with ethidium bromide added to a final concentration of 
0.5 μg/ml in the gel. Sample DNA (10 μl) was mixed with 3 μl Orange mix loading dye and 
loaded on to the gel. Gels were run at 60-120V (2-4 V/cm) for 60 minutes and DNA patterns 
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were visualised using a UV transilluminator (BioRad). A 1kb DNA ladder, λ/BstEII, were 
used as size marker (NEB). 
 Agarose gel electrophoresis can also be used as a preparative tool, i.e. use 
electrophoresis to separate DNA fragments by their size and afterwards cut the DNA, 
corresponding to fragment size of sample, out of the gel for further use. This is preformed by 
using a scalpel, a UV transilluminator and gel purification kits. 
   
                                    




PCR products were purified directly from the PCR mixture by QIAquick PCR 
purification kit (Qiagen). Alternatively, preparative agarose gel electrophoresis was used to 
separate PCR products (2.3.4), and gel bands were purified by QIAquick Gel extraction kit 
(Qiagen). The QIAquick system combines spin-column technology with selective binding 
properties of a silica-gel membrane. DNA is absorbed to the silica-gel membrane in the 
presence of high salt while contaminants pass through the column. Special buffers provided 
with kit are optimized for efficient recovery of DNA and removal of contaminants. When gel 
purification was preformed 0.8% Seakem GTG agarose gel (1x TAE buffer) was used to give 





2.3.6 Plasmids and preparation 
pUC19 was used as a cloning vector in this project (Figure 6.2.1). pUC19 vector was 
isolated from an E. coli strain in our strain collection (AH 1352), using the QIAprep Midiprep 
kit (Qiagen) following manufacturers guidelines. QIAprep midiprep kit is based on alkaline 
lyses of bacterial cells followed by absorption of DNA onto silica in presence of high salt. 
Elution is done in low-salt buffers. Manufactures guidelines were followed. 
 
2.3.7 Restriction enzyme digest 
 Restriction enzymes were used to digest plcR upstream and plcR downstream PCR 
products, as well as vector pUC19. Manufacturer’s guidelines were followed for temperature 
during digestion, concentrations of reactants and the use of bovine serum albumin (BSA). 
Enzymes were allowed to incubate for three hours. 
 
Restriction enzyme digestion (30 μl volume per tube): 
5 μl Buffer (corresponding to manufacturers guidelines for the given enzyme) 
0.5 μl BSA (corresponding to manufacturers guidelines for the given enzyme) 
1 μl enzyme 1 
1 μl enzyme 2 (if double digest) 
 1-5 μl template 







For the double digests performed in this thesis, the following recommended guidelines 
were followed: 
 
Supplements % Activity in NEBufferEnzyme Cat# Temp Supplied NEBuffer
BSA SAM 1 2 3 4 
Kpn I R0142 37°C NEBuffer 1 Yes No 100 75 0 50 
Sac I R0156 37°C NEBuffer 1 Yes No 100 50 10 100 
 
Double Digest Recommendation(s) for Kpn I + Sac I: 
Digest in NEBuffer 1 + BSA at 37 °C.   
Table 2.3: Double digest recommendations for restriction enzymes Kpn I and Sac I, used to cut the 
plcR-upstream PCR product (www.neb.com) 
Supplements % Activity in NEBufferEnzyme Cat# Temp Supplied NEBuffer
BSA SAM 1 2 3 4 
BamH I R0136 37°C NEBuffer BamH I Yes No 75 100 50 75 
Sal I R0138 37°C NEBuffer 3 Yes No 0 0 100 0 
 
Double Digest Recommendation(s) for BamH I + Sal I: 
Digest in NEBuffer BamH I + BSA at 37 °C.  
Table 2.4: Double digest recommendations for restriction enzymes BamH I and Sal I, used to cut the 
plcRdownstream PCR product (www.neb.com) 
Supplements % Activity in NEBufferEnzyme Cat# Temp Supplied NEBuffer
BSA SAM 1 2 3 4 
EcoR I R0101 37°C NEBuffer EcoR I No No 100 100 100 100 
Hind III R0104 37°C NEBuffer 2 No No 50 100 10 50 
 
Double Digest Recommendation(s) for EcoR I + Hind III: 
Digest in NEBuffer EcoR I at 37°C. 
Table 2.5: Double digest recommendations for restriction enzymes EcoR I and Hind III, used to cut the 




2.3.8 Dephosphorylation of linearized vector 5’ ends 
 In some instances, when using only one restriction enzyme in cutting reactions, 
treatment with calf alkaline phosphatase (CIP) was used to remove phosphate groups at the 5’ 
end of the vector to prevent religation of plasmid without insert.  
 
CIP reaction mixture: 
2 μl CIP (NEB) (diluted 10 times with MilliQ-water) 
4 μl DNA template 
The reaction mixture was incubated at 37ºC for 1 hour. 
 
2.3.9 Ligation and Transformation 
 After PCR product and cloning vector were cut with corresponding restriction 
enzymes, the PCR product was ligated into the cloning vector (pUC19) and transformed into 
competent E. coli cells. Amounts of PCR product and plasmid vector in the ligation reaction 
were determined from agarose gel visualisation and the principal that there was to be a 1:5 
molar ratio of plasmid to insert was followed.  
 
Ligation mixture (total volume 20 μl): 
1-5 μl insert  
10-15 μl plasmid 
2 μl T4 DNA ligase (NEB) 
2 μl T4 DNA ligase buffer (NEB) 
MilliQ-water to 20 μl 
Ligation mixture was incubated overnight at 16ºC. 
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To transform, 5 μl of ligation mixture was added to 50 μl One Shot TOP10 Competent 
cells (Invitrogen). One Shot TOP10 competent cells are cells made competent, i.e. able to take 
up foreign DNA via plasmids transformed to requirements. One Shot TOP10 competent cells 
have a transformation efficiency of ~1 x 109 cfu/μg DNA. Manufacturer’s guidelines were 
followed. Transformed competent cells (50-200 μl) were plated on LB agar containing 100 
μg/ml ampicillin and grown over night at 37ºC. Self-ligated pUC19 was always used as 
ligation and transformation control and showed that manufacturer’s transformation efficiency 
concurred with our results. The subsequent single colonies were picked and grown overnight 
in 10 ml LB-medium at 37ºC and shaking (225 rpm). 3 ml of over night culture was used for 
plasmid purification, using QIAprep Miniprep kit (Qiagen). QIAprep miniprep kit is based on 
alkaline lyses of bacterial cells followed by absorption of DNA onto silica in presence of high 
salt. Elution is done in low-salt buffers. Manufactures guidelines were followed. 
 The presence and product size of insert in plasmid was checked by corresponding 
restriction enzyme digestion (2.3.7) and agarose gel electrophoresis (2.3.4) to visualise 
presence or absence of plasmid containing the expected insert. 
 
2.3.10 Sequencing 
 Sequencing of constructs was performed at the Institute of Molecular Bioscience, 
University of Oslo, Oslo, Norway, on plasmids (pUC19) containing inserts of different origin. 
Sequencing of plasmid vector clones (pUC19) containing resistance cassettes was done by 






2.3.11 Sequence Analysis 
DNA sequences were viewed using GATCViewer 1.00 sequence analysis software 
(GATC Biotech, Germany), aligned using Vector NTI Suite 9 (Contig Express Project) and 























3.1 Colony morphology of strains screened for biofilm 
 The morphology and the bacterial colony structure was speculated to be linked to a 
strains ability to form biofilm and strains were therefore grown on LB agar at 30ºC, over 
night, for use in growth experiments, for use in biofilm screening and to investigate whether 
colony morphology could be correlated to the strains ability to form biofilm. Strain colonies 
depicted (Picture 3.1 – 3.2) are both biofilm-positive (+) and biofilm-negative (-) strains and 
did, in reference to results of biofilm screening, show that the colony morphology of the 
strains is independent of their biofilm formation ability. For the Bacillus cereus group bacteria 
the morphology of the colonies are somewhat different, but differences are seen mainly in the 
size of the colonies and the general shape of the colonies. Some strains, e.g. AH 183 and AH 
1031, form larger colonies with a somewhat jagged outline, while other strains, e.g. AH 75 
and AH 1248, form smaller colonies with a smooth outline.  
The only strain with uncharacteristic colony morphology for B. cereus or B. 
thuringensis was AH 884. This strain showed a “slime-like” growth, with no presence of 
single colonies, and came especially to our attention because it was seen to be a very strong 
biofilm former (3.3.4). AH 884 is a clinical isolate, isolated from patient blood 
(Rikshospitalet, Oslo, Norway), and was originally characterised B. cereus. However, 16S 
rRNA sequencing performed during this study (Erlendur Helgason, personal communication), 
identified AH 884 as Bacillus licheniformis, which are known for their abilities to form 




    
 
 
    
 
 
    
Picture 3.1: Colony morphology of biofilm-positive (+) and biofilm-negative (-) strains; Bacillus cereus AH 75 








Picture 3.2: Colony morphology of biofilm-positive (+) and biofilm-negative (-) strains; Bacillus cereus AH 
884 (+), AH 1031 (+) and AH 1248 (-) grown on LB agar, ON, at 30ºC. 
   
3.2 Growth curves 
3.2.1 Standard growth curve for reference strains 
 Standard growth curve experiments (2.2.2) were done to see and to verify the ability 
for the strains to reach exponential phase at approximately the same time point (Figure 3.1). 
To produce this standard growth curve, the three reference strains (B. cereus ATCC 10987 
(biofilm-positive), B. cereus ATCC 14579 (biofilm-negative) and B. thuringensis 407 
(biofilm-positive)) were used and results used as indicative for all 81 strains throughout the 
biofilm screening. 
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 For this experiment were strains grown for 5 hours, at 30ºC and shaking at 225 rpm, in 
a total volume of 200 ml LB medium, in a 1 l flask. Every half hour, 1 ml samples were taken 
and measured (OD600). 
 
 



























Figure 3.1: Standard growth curve for reference strains Bacillus cereus ATCC 10987, Bacillus cereus ATCC 
14579 and Bacillus thuringensis 407, grown in LB medium at 30ºC and 225 rpm. 
 
 
The standard growth curve for reference strains (Figure 3.1) indicated that the different 
strains grow with similar speed and reach exponential growth phase at approximately the 
same time point, 3 hours into incubation at 30 ºC and 225 rpm. No difference between strains 
forming biofilm and those that do not, in the rate of growth, could be indicated or observed. 
This time point was therefore used consequently as time point for the extraction of samples 
for use during growth in microtiter plates. 
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3.2.2 Standard growth curves for selected biofilm screened strains 
 Standard growth curve experiments (2.2.2) were done using a group of selected 
strains, which were used during screening for biofilm formation. This was done to see and to 
verify, such as with the reference strains, if the ability for the strains to reach exponential 
growth phase at approximately the same time point was certain. To produce this standard 
growth curve, five strains, both biofilm-positive (+) and biofilm-negative (-), used during the 
biofilm screening were picked (Figure 3.2). 
 
 






























Figure 3.2: Growth curve of selected biofilm screened strains; B. cereus ATCC 10987 (+), B. cereus ATCC 
14579 (-), B. cereus AH 1271 (-), B. cereus AH 1352 (-) and B. thuringensis 407 (+), grown in LB medium, at 
30ºC and 225 rpm. 
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The standard growth curve for selected biofilm screened strains (Figure 3.2) indicated 
that the different strains grow with similar speed and reach exponential growth phase at 
approximately the same time point, 3 hours into incubation at 30 ºC and 225 rpm. No 
difference is observed between strains known to form biofilm and those strains known not to 
form biofilm. This again indicated that cultures, after 3 hours of growth, could be used 
consequently as time point for the extraction of samples for use during growth in microtiter 
plates. 
 
3.2.3 Crystal violet staining of serial dilutions of bacterial strains 
 Crystal violet was used in the biofilm screening procedure as a dye to indicate the 
presence of cells left in the microtiter plate wells after incubation and wash, and therefore also 
used to indicate the level of biofilm formed by the strain. A serial dilution of bacteria, which 
would be subsequently dyed with crystal violet, allowed us to observe the relationship 
between the amount of cells dyed and the absorbance of crystal violet measured. 
 Reference strains Bacillus cereus ATCC 10987, Bacillus cereus ATCC 14579 and 





























Figure 3.3: Crystal violet staining of bacterial serial dilution using B.  cereus ATCC 10987, B. cereus ATCC 
14579 and B. thuringensis 407, serial diluted and stained with crystal violet. The data represents the mean of four 
independent experiments, and error bars indicate standard deviation. 
  
The results (Figure 3.3) indicated that the amount of bacterial cells present in the 
sample corresponded roughly to the absorbance of crystal violet at 590 nm. This is clearly 
linked with the biofilm screening procedure in the way that the amount of bacterial cells left 
in the wells after incubation and have formed a biofilm, will be stained by the crystal violet, 
and furthermore indicated that the amount of crystal violet measured at 590nm is linked to the 






3.3 Biofilm screening 
 The screening of strains for the formation of biofilm was preformed, due to the aims of 
this project, to be able to collect information on a strains ability to form biofilm.   
 
3.3.1 Establishing the biofilm screening method 
 To establish the method for biofilm screening, four strains were selected. These four 
strains were selected due to background knowledge (Michel Gohar, personal communication) 
of their ability to form biofilm (+) or of not to form biofilm (-). The establishment of the 
biofilm screening method, using strains of known biofilm forming abilities, was done to make 
sure that the method used in our laboratory gave the same result as other laboratories. The 
following strains were selected for the establishment of the biofilm screening method in our 
laboratory: 
 
• Bacillus cereus ATCC10987 (AH 75) (+) 
• Bacillus cereus ATCC14579 (AH 183) (-) 
• Bacillus cereus AH 812 (-) 
• Bacillus thuringensis 407 (AH 1031) (+) 
 
Strains were plated from -70ºC stock on LB agar and grown over night at 30ºC, a 
single colony was picked and inoculated in 10 ml LB medium, and grown over nigh at 30ºC 
and 225 rpm. Over night culture (100μl) was grown for 3 hours in 10 ml LB medium, at 30ºC 
and 225 rpm. After 3 hours of growth, 50μl of the culture was added to 10 ml Bactopeptone 
medium and 125 μl of this suspension was transferred to each well of three 96-well microtiter 
plates. For initial experiments, Costar flat well, 96-well microtiter plates were used. Microtiter 
plates were incubated for 24, 48 and 72 hours respectively, at 30ºC, washed with PBS 
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(150μl), stained with crystal violet (130μl) and washed with PBS (180μl) three times. 
Attached cells were resuspended in acetone/ethanol (1:4) (150μl) and absorbance measured at 
590nm (2.2.3). 
The results are shown in figure 3.4, 3.5 and 3.6:  
 
Biofilm formation / 24 hours









AH 183 / ATCC 14579
AH 75 / ATCC 10987
 
Figure 3.4: Absorbance (590nm) after 24 hours growth for B. cereus ATCC 10987, B. cereus ATCC 14579, B. 
cereus AH812 and B. thuringensis 407. Negative control is Bactopeptone medium incubated in the same 
conditions as the other samples. 
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Biofilm formation / 48 hours
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Figure 3.5: Absorbance (590nm) after 48 hours growth for B. cereus ATCC 10987, B. cereus ATCC 14579, B. 
cereus AH812 and B. thuringensis 407. Negative control is Bactopeptone medium incubated in the same 
conditions as the other samples. 
 
Biofilm formation / 72 hours









AH 183 / ATCC 14579
AH 75 / ATCC 10987
C
 
Figure 3.6: Absorbance (590nm) after 72 hours growth for B. cereus ATCC 10987, B. cereus ATCC 14579, B. 
cereus AH812 and B. thuringensis 407. Negative control is Bactopeptone medium incubated in the same 
conditions as the other samples. 
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The results showed that the known biofilm forming strains, B. cereus ATCC 10987 
and B. thuringensis 407 were positive in this assay, while the known non biofilm forming 
strain, B. cereus ATCC 14579 was negative in this assay after 24 and 48 hours of incubation, 
but positive after 72 hours of incubation. B. cereus AH 812 gave a positive result at all three 
time points, but values were somewhat lower than B. cereus ATCC 10987 and B. thuringensis 
407. Standard deviation and background signal was however relatively high for this set of 
experiments. 
These test experiments did show that there are clear differences in the degree of 
attachment of bacterial cells, the retention of crystal violet by those cells and the absorbance 
of crystal violet at 590 nm between a biofilm forming strains, such as B. thuringensis 407, and 
non biofilm forming strains, such as B. cereus ATCC 14579. These test experiments also 
verified that the method used in our laboratory gave the same results as in other laboratories, 
indicating that our method is viable and useful. As seen, the negative control (pure 
bactopeptone medium), did give some background signal, which could be seen due to 
retention of unspecific bound crystal violet in the wells. This background signal was later 
subtracted from the final absorbance measured for the 81 strains tested. 
  
3.3.2 Optimization of biofilm screening method 
 Optimization of the biofilm screening method was preformed to be able to establish a 
method, which could be reproducible, reliable and give certain results through measurement 
of absorption and visualization of the biofilm ring formation after staining with crystal violet. 
When growing bacteria in such conditions, in a microtiter plate, there are many factors, which 
can possibly have an effect on the growth of the bacteria and the formation of biofilm, and 
there were these uncertainties, which were wished to be removed. Several different 
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parameters of the biofilm screening method were varied to control and to optimize the 
method. 
 For the optimization of the biofilm screening method, four strains, same four as used 
for establishment of the method (3.3.1), were picked and used under all the different 
conditions tested. These parameters were tested, first individually and later in combination to 
see if they had any effect on the screening method:  
i) The first parameter to be examined was the microtiter plates used in the screening. 
Earlier studies (Michel Gohar, personal communication) had shown that PVC 
based microtiter plates gave the best conditions for B. cereus group bacteria to 
form biofilm and that microtiter plates with round-bottomed wells allowed the 
bacteria to form a better and stronger biofilm. This resulted in the switch from flat-
bottomed microtiter plates (Costar 2595 96-well flat bottomed PVC microtiter 
plates) to round-bottomed microtiter plates (Falcon 353911 96-well round 
bottomed PVC microtiter plates, picture 3.3). 
 
 
Picture 3.3: Falcon, PVC, round-bottom, 96-well microtiter plate. 
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ii) The use of bactopeptone medium, i.e. medium there tryptone had been replaced 
with bactopeptone, for the incubation in the microtiter plates, had been seen to 
increase the ability of B. cereus strains to form biofilm and was therefore used 
when cultures were grown in the microtiter plates (Michel Gohar, personal 
communication).  
iii) From immunological studies, the positioning of samples, the amount of culture in 
each well and the use of buffers in a microtiter plates have been seen to have an 
effect, e.g. when labelling with antibodies. This was therefore tested for to be able 
to exclude as an interfering variation. The four tested strains were placed in 
different positions on the microtiter plate, incubated with different volumes 
(100μl-200 μl) in each well and buffer (PBS and H2O) was added in surrounding 
wells. The positioning of the samples in different places on the microtiter plates 
and the amounts of culture in each well showed no effect on the ability to form 
biofilm. However, the incubation with water present in the surrounding wells was 
seen to give stronger biofilm formation for biofilm-positive strains. This, most 
likely, due to the effect moister had to hinder the cultures from drying during 
incubation. The incubation of the microtiter plates on top of a moist filter paper 
was therefore seen to give better growth conditions. The use of lids for the 
microtiter plates (Falcon 353913) and the incubation of the microtiter plates inside 
a closed (with lid) container also allowed the cultures in the microtiter plates to 
experience better growth conditions (results not shown). 
iv) During initial experiments (3.3.1), the unspecific binding of crystal violet to PVC 
in the wells was seen to give a high level of background signal and to increase the 
level of standard deviation. Sterile filtration of the dye, crystal violet, (using a 0.45 
μm filter) was therefore performed and seen to reduce unspecific binding of crystal 
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violet to PVC. This resulted in the reduction of background signal, the subsequent 
reduction of standard deviation and allowed clearer positives and negatives to be 
observed.  
 
The optimized screening method was as followed: For each time point, 24, 48 and 72 
hours, two Falcon 353911 96-well round bottomed PVC microtiter plates were inoculated 
identically, with the same strain inoculated in 8 wells on each plate, giving a total of 16 
parallel samples for each strain screened, for which the mean value gave the final score. 
Strains were inoculated in bactopeptone and microtiter plates were incubated with lid and on 
moist filter paper. 
 
Even in the optimized screening method was a high level of background signal 
observed, resulting in high standard deviation. This indicated that crystal violet did, by itself, 
bind to the wells. Unspecific binding of crystal violet was observed in some wells in each 
parallel, which in turn gave high levels of absorbance and subsequently aided to the rise of the 
standard deviation. The unspecific binding of crystal violet was not seen to be affected by the 
time of incubation of the microtiter plate (24, 48 or 72 hours), but somewhat affected by the 
time the crystal violet was allowed to stain the well. 20 minutes of staining was seen to give 
the best result, i.e. cells were stained properly and unspecific binding was reduced as much as 
possible. 
For every microtiter plate screened, the positive control Bacillus thuringensis 407, the 
negative control B. cereus ATCC 14579 and pure bactopeptone medium were added to the 
plate to use as control of test systems consistency (Picture 3.4). 
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 Picture 3.4: Microtiter plate containing 125 μl culture in first three rows, Bacillus thuringensis 407, Bacillus 
cereus ATCC14579 and pure bactopeptone medium. 
 
As observed in picture 3.5 the positive control, B. thuringensis 407, produces a ring of 
crystal violet in the air-liquid interface of the well. This ring indicated that the cells have 
attached to the well wall and further indicates that a biofilm has been formed. The well of the 
negative control, B. cereus ATCC 14579, and the well incubated with pure bactopeptone did 
show some ring formation, but this is however where the air-liquid interface was when the 
wells were stained with crystal violet and indicated unspecific binding. After ring had been 
dissolved with acetone/ethanol (1:4) (Picture 3.6), colour absorbance gave indication to the 
amount of crystal violet bound to the well wall. 
 
 
Picture 3.5: Biofilm ring formation after staining with crystal violet, right to left; Bacillus thuringensis 407, 
Bacillus cereus ATCC14579 and pure bactopeptone medium. 
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 Picture 3.6: Wells after addition of acetone/ethanol (1:4), left to right; Bacillus thuringensis 407, Bacillus cereus 
ATCC14579 and pure bactopeptone medium. 
 
 
3.3.3 Screening for biofilm formation in Bacillus cereus group bacteria 
 To screen 81 strains from a B. cereus group strain collection available in the research 
group, the optimized biofilm method was used (3.3.2). Screening results are presented as 
mean absorbance for each strain with background signal deducted. The results presented (3.7 - 
3.30) do therefore not include standard deviation. Please see appendix (6.1) for raw data, 
including standard deviation for each experiment.  
 To be able to determine biofilm-positive strains and biofilm-negative strains, some 
criteria were set. The ability to form biofilm was determined through two linked analysis 
methods; i) the presence of the ring after staining the well with crystal violet, and, ii) the level 
of crystal violet absorbance. The presence of the ring after crystal violet staining was easy to 
observe and to document (Picture 3.5) and equally easy was the measurement of crystal violet 
absorbance (590 nm) after crystal violet solubilisation (Picture 3.6). However, the level of 
absorbance after solubilisation had to be compared to the negative control used, background 
signal deduction and standard deviation. When ring was observed, absorbance of crystal 
violet was high and standard deviation was low, the strain was marked positive for biofilm 
formation. When no ring was observed, absorbance of crystal violet was low and standard 
deviation was high, the strain was marked negative for biofilm formation. As with all 
scientific experiments, some strains came in between these criteria and were dismissed as 
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biofilm positive strains due to lack of ring formation or re-checked (3.3.4). These criteria did 
result in the confirmation of 7 biofilm forming strains for future studies (Table 3.1). 
 
 






























Figure 3.7: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.8: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 



























Figure 3.9: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.10: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 
































Figure 3.11: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.12: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 





























Figure 3.13: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.14: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 





























Figure 3.15: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.16: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 




























Figure 3.17: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.18: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 





































Figure 3.19: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.20: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 



































Figure 3.21: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.22: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 




































Figure 3.23: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.24: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 


































Figure 3.25: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.26: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 


































Figure 3.27: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.28: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 


































Figure 3.29: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.30: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 
 
 As mentioned, after screening 81 strains, were 7 strains observed to form biofilm and 
were determined biofilm-positive strains, while 74 strains were observed not to form biofilm 
and were determined biofilm-negative strains. The levels of absorbance seen for positive and 
negative control were relatively stabile, but do vary in figures above due to somewhat 
different levels of background signal for each experiment. Differences seen at the different 
time points, 24, 48 and 72 hours, were taken into consideration when positive strains were 
picked for second round of screening (3.3.4). One could see some strains giving high levels of 
absorbance at 24 hours, but not at 48 or 72 hours, or visa versa, and this was only seen for 
strains, which did not form a ring after crystal violet staining. These strains were determined 
as biofilm-negative, because only observation of high levels of absorbance was not sufficient 
to determine a strain biofilm-positive. 
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3.3.4 Biofilm positive strain confirmation 
 The 7 strains, which were characterized as biofilm-positive, either by observing a 
consistently present biofilm ring in the wells (Picture 3.7 – 3.8) or by high levels of retained 
crystal violet measured (Figure 3.31 – 3.33), and 4 strains characterized as biofilm-negative, 
either by lack of observing a consistently present biofilm ring in the wells or by low levels of 
retained crystal violet measured, were screened separately to confirm the positive strains 
ability to form biofilm. The ability to form biofilm was visualised as a ring in the wells 
(Picture 3.7), after staining with crystal violet, and absorbance at 590nm measured after 
solubilisation (Picture 3.8; Figure 3.31 – 3.33). The presence of negative control, pure 
bactopeptone, was added to show the levels of background signal seen in all experiments.  
 
 
Picture 3.7: Biofilm ring formation for biofilm-positive (+) and biofilm-negative (-) strains, after 72 hours 
incubation. Left to right; AH75 (+), AH604 (+), AH226 (+), AH405 (+), AH183 (-), AH815 (+), AH884 (+), 
AH1031 (+), AH1248 (-), AH1271 (-), AH1353 (-) and negative control (pure bactopeptone medium). 
 
 
Picture 3.8: Solubilised crystal violet stained biofilm rings, after 72 hours incubation. Biofilm-positive strains 
(+), biofilm-negative (-) strains and negative control were screened. Left to right; AH75 (+), AH604 (+), AH226 
(+), AH405 (+), AH183 (-), AH815 (+), AH884 (+), AH1031 (+), AH1248 (-), AH1271 (-), AH1353 (-) and 
negative control (pure bactopeptone medium). 
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Figure 3.31: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
(background signal from negative control deducted) 


































Figure 3.32: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
(background signal from negative control deducted) 
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Figure 3.33: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control deducted) 
  
 
These results clearly indicated that the 7 out of the 81 strains tested in this screening 
method where biofilm-positive (Table 3.1). However this also showed that for B. cereus AH 
604, the presence of the ring and level of absorption was reduced after 72 hours, compared to 
after 24 and 48 hours. Also for B. cereus AH 1248, AH 1271 and AH 1353, which did show 
some level of absorbance after 72 hours, the presence of the biofilm ring was not seen and 
they were therefore determined biofilm-negative. 
 The frequency for biofilm formation was seen to be ~9% (7 biofilm-positive strains / 





Table 3.1: Biofilm formation according to strain origin. (-) indicates strains that do not form biofilm, while (+) 
indicates strain that do form biofilm. 
Strain     Origin     Biofilm formation 
AH 75  Bacillus cereus ATCC 10987 (dairy)     + 
AH 181  Bacillus cereus ATCC 10876      - 
AH 183  Bacillus cereus ATCC 14579 (dairy)     - 
AH 186  Bacillus cereus F4433/73              - 
AH 187  Bacillus cereus F4810/72 (vomit, patient)     - 
AH 188  Bacillus cereus F837/76       - 
AH 189  Bacillus cereus F2038/78       - 
AH 226  Bacillus cereus ATCC 4342 (dairy)     + 
AH 248  Bacillus thuringensis, subsp. kurstaki 4D1     - 
AH 249  Bacillus thuringensis, subsp. kurstaki 4D4     - 
AH 252  Bacillus thuringensis, subsp. kurstaki 4H2     - 
AH 257  Bacillus thuringensis, subsp. israelensis 4Q1    - 
AH 258  Bacillus thuringensis, subsp. israelensis 4Q5    - 
AH 259  Bacillus cereus 6A1       - 
AH 265  Bacillus thuringensis 4A4       - 
AH 338  Bacillus mycoides (soil)       - 
AH 401  Bacillus cereus 181 (dairy)      - 
AH 404  Bacillus cereus 3048 (dairy)      - 
AH 405  Bacillus cereus 1230 (dairy)      + 
AH 407  Bacillus cereus 3122 (dairy)      - 
AH 513  Bacillus cereus s1-2 (soil)       - 
AH 535  Bacillus cereus s2-21 (soil)      - 
AH 543  Bacillus cereus s3-1 (soil)       - 
AH 546  Bacillus cereus s3-5 (soil)       - 
AH 560  Bacillus cereus s4-3 (soil)       - 
AH 580  Bacillus cereus s4-24 (soil)      - 
AH 584  Bacillus cereus s4-28 (soil)      - 
AH 588  Bacillus cereus s4-32 (soil)      - 
AH 595  Bacillus cereus vet-1 (dairy)      - 
AH 597  Bacillus cereus vet-3 (dairy)      - 
AH 599  Bacillus cereus vet-5 (dairy)      - 
AH 601  Bacillus cereus vet-8 (dairy)      - 
AH 603  Bacillus cereus vet-10 (dairy)      - 
AH 604  Bacillus cereus vet-11 (dairy)      + 
AH 605  Bacillus cereus vet-17 (dairy)      - 
AH 607  Bacillus cereus vet-59 (dairy)      - 
AH 608  Bacillus cereus vet-61 (dairy)      - 
AH 609  Bacillus cereus vet-68 (dairy)      - 
AH 611  Bacillus cereus vet-87 (dairy)      - 
AH 612  Bacillus cereus vet-131 (dairy)      - 
AH 613  Bacillus cereus vet-132 (dairy)      - 
AH 623  Bacillus cereus (soil)       - 
AH 631  Bacillus cereus (soil)       - 
AH 648  Bacillus cereus (soil)       - 
AH 652  Bacillus cereus (soil)       - 
AH 656  Bacillus cereus (soil)       - 
AH 681  Bacillus cereus (soil)       - 
AH 691  Bacillus cereus (soil)       - 
AH 699  Bacillus subtilis 168       - 
AH 724  Bacillus cereus (urine, patient)      - 
AH 810  Bacillus cereus (periodontitis, patient)     - 
AH 811  Bacillus cereus (periodontitis, patient)     - 
AH 812  Bacillus cereus (periodontitis, patient)     - 
AH 813  Bacillus cereus (periodontitis, patient)     - 
AH 814  Bacillus cereus (periodontitis, patient)     - 
AH 815  Bacillus cereus (periodontitis, patient)     + 
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Strain     Origin     Biofilm formation 
AH 816  Bacillus cereus (periodontitis, patient)     - 
AH 818  Bacillus cereus (periodontitis, patient)     - 
AH 819  Bacillus cereus (periodontitis, patient)     - 
AH 820  Bacillus cereus (periodontitis, patient)     - 
AH 831  Bacillus cereus (periodontitis, patient)     - 
AH 874  Bacillus cereus SIC (clinical, patient)     - 
AH 884  Bacillus cereus (blood, patient)      + 
AH 892  Bacillus cereus (wound after insect bite, patient)    - 
AH 1031 Bacillus thuringensis 407 (soil)      + 
AH 1091 Bacillus cereus ATCC14579 (dairy, cured of linear 15kb-plasmid)  - 
AH 1123 Bacillus cereus 9823 (clinical)      - 
AH 1127 Bacillus cereus 9843 (clinical)      - 
AH 1129 Bacillus cereus Bc004 (clinical, post-traumatic endophtalmitis)  - 
AH 1134 Bacillus cereus Bc006 (clinical, post-traumatic endophtalmitis)  - 
AH 1143 Bacillus weihenstephanensis WSBC 10201     - 
AH 1146 Bacillus weihenstephanensis WSBC 10205     - 
AH 1248 Bacillus thuringensis subsp. konkukian str. 97-27 (leg wound infection) -  
AH 1270 Bacillus cereus 0001+31175 (cervix, patient)    - 
AH 1271 Bacillus cereus 9903+02049 (secretary lamp)    - 
AH 1273 Bacillus cereus 9708+03060 (blood, patient)    - 
AH 1295 Bacillus cereus (veterinary)      - 
AH 1297 Bacillus cereus (veterinary)      - 
AH 1353 Bacillus cereus (food poisoning, diarrhoeal outbreak)   - 
AH 1363 Bacillus cereus ATCC14579 (dairy, ΔplcR mutant)    - 




3.3 Construction of a plcR knock-out of Bacillus cereus ATCC 10987 
 There are a wide variety of molecular pathways involved in the formation of biofilm 
amongst bacteria and therefore probably also in Bacillus cereus group bacteria. In this study, 
a candidate gene, plcR, found in the genome of B. cereus group bacteria, was investigated for 
involvement in biofilm formation. plcR was chosen as a candidate gene due to its observed 
role as a pleitropic regulator of gene expression, and to the fact that PlcR has been observed to 
be expressed in biofilm (Michel Gohar, personal communication). B. cereus ATCC 10987 
was chosen as the target strain for plcR gene disruption due to the fact that it is seen to form 
biofilm, its culture supernatant has the ability to induce biofilm formation in otherwise 
biofilm-negative strains, and is a strain which is fully sequenced (Rasko et al., 2004), and 
therefore is possible to use in molecular studies. 
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 3.3.1 Knock-out construct cloning and antibiotic resistance markers 
 For the construction of the knock-out clone, the use of cloning plasmids, expression 
plasmids, antibiotic resistance markers and restriction enzymes are essential tools. Figure 3.34 
shows how the construction of the plcR locus knock-out clone in pUC19 was intended to be 

























Figure 3.34: Method and way of cloning constructed plcR locus knock-out clone in pUC19 into pAT113 and 
using pAT113 as cloning vector for gene disruption of entire plcR locus in B. cereus ATCC 10987. 
 
 
 Resistance to antibiotics is an essential when screening clones for the presence of 
plasmid following transformations. The pUC19 plasmid contains an ampicillin resistance 
gene (Figure 6.28) conferring transformed bacterial cells resistance if grown on this antibiotic. 
However, there must also be present a second antibiotic resistance gene in the final knock-out 




















has occurred. For this procedure a spectinomycin- and an erythromycin-resistance gene 
cassette is cloned into to the knock-out construct. The spectinomycin resistance gene used 
here was originally from Enterococcus faecalis and works as a protein synthesis inhibitor by 
binding to the 30S subunit of bacterial ribosomes and inhibiting the translocation of peptides 
(LeBlanc, et al. 1991), while the erythromycin resistance gene was from Staphylococcus 
aureus and works as a protein synthesis inhibitor by binding to the 23S rRNA molecule in the 
50S of the bacterial ribosome,  an action, which blocks the exit of the growing peptide chain 
and thus inhibiting the translocation of peptides (Horinouchi, et al. 1980). 
 
The multiple cloning site (MCS) present in pUC19 allows the linearization of the 
plasmid, the digestion of the plasmid by restriction enzymes (2.3.7)  and the insertion of plcR 
upstream, plcR downstream, the antibiotic resistance cassette into the plasmid and movement 
of the entire construct from pUC19 into pAT113. plcR upstream was to be cloned into the 
KpnI/SacI site, plcR downstream was to be cloned into the BamHI/SalI site and the resistance 
cassettes were to be cloned into the SmaI site. EcoRI and HindIII were to be used to move 
entire construct from pUC19 into pAT113. See figure 3.35 for the sites present in the MCS, 







Figure 3.35: Multiple cloning site (MSC) of pUC19, showing selected restriction sites. 
 
 
EcoRI SacI KpnI SmaI BamHI SalI HindIII 
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3.3.2 plcR locus sequence extraction and primer design 
 The construction of a plcR deletion mutant of Bacillus cereus ATCC 10987 was 
initiated with sequence analysis of the chromosomal region surrounding plcR. The genome 
region containing the plcR gene was extracted from EMBL entry AE017281 using extractseq 
from the EMBOSS sequence analysis suite (www.biotek.uio.no/EMBNET), including 1000 
bp of flanking regions from each end of the plcR gene. One primer set for PCR was to be 
selected from genome region: 157256-156256 (-1000 bp) and another set was to be selected 
from genome region: 158113-159113 (+1000 bp). These sequences were tested for restriction 
sites KpnI, SacI, SalI, BamHI, SmaI, EcoRI and HindIII (restrict-program in EMBOSS) and 
no restriction sites were found. primer3 (http://frodo.wi.mit.edu) was then used to design 
primers for the genome regions upstream and downstream of plcR, using default criteria. 
















SacI site underlined 
















Table 3.2: Primers of the upstream and downstream regions of the plcR-locus from B. cereus ATCC 10987 used 
in PCR to produce fragments for making the PlcR knock-out construct. 
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 The primers were produced with terminal restriction sites to aid the cloning of the 
fragments in a plasmid vector (e.g. pUC19). This also allowed the cloning of the fragments in 
a correct orientation into the vector multiple cloning site (MCS/polylinker region). See Figure 
6.28 for an overview of vector pUC19. 
 
3.3.3 Isolation of template DNA for PCR amplification 
 DNA from Bacillus cereus ATCC 10987 was extracted (2.3.2), to be used as template 
to produce the plcR upstream- and the plcRdownstream-fragments by PCR (2.3.3). Also, 
plasmids from clones AH 1337, containing the spectinomycin resistance cassette cloned in 
pUC19 (Figure 3.36), and AH 1363, containing the erythromycin resistance cassette cloned in 
pUC19 (Figure 3.36), were isolated by plasmid preparation (2.3.6). These plasmids were to be 




         pUC19 





Figure 3.36: pUC19 vector, showing multiple cloning site (MSC), replication site (rep (pMB1)), 
ampicillin resistance cassette (bla (ApR)) and lacZ gene. 
 
 76
Agarose gel electrophoresis allowed observation of DNA extracted from B. cereus 
ATCC 10987 (Picture 3.9), plasmids extracted from AH 1337 and AH 1363 (Picture 3.10) 
and also allowed the quantification of DNA/plasmid amounts present in the sample. 
       1     2 
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  







Picture 3.9: Agarose gel electrophoresis of extracted DNA from B. cereus ATCC 10987 (lane 2) and size 
marker lambda/BstE II (lane 1). 
 
Plasmids, pUC19_spectinomycin and pUC19_erythromycin, were digested with EcoR 
I (2.3.7) for verification of size and concentration through agarose gel electrophoresis (2.3.4).  
         1       2        3 
                                                            
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  







Picture 3.10: Agarose gel electrophoresis of linearized plasmids (EcoRI digested) isolated from AH 1337 (lane 
2) and AH 1363 (lane 3). Size marker lambda/BstE II (lane 1). 
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 B. cereus ATCC 10987 DNA sample was observed as clean and in large amounts, 
while plasmids containing the spectinomycin- and erythromycin-resistance cassettes were of 
expected sizes, clean and in large amounts. 
 
3.3.4 PCR of plcR flanking regions and resistance cassettes 
 The 772 bp upstream region and the 891 bp downstream region of the plcR gene were 
amplified by PCR (2.3.3) using primers made for the specific sequences (Table 3.2; Figure 
3.37) and Bacillus cereus ATCC 10987 DNA (3.3.3) was used as template. The 
spectinomycin-cassette and the erythromycin-cassette where also amplified by PCR (2.3.3), 
using purified plasmids from AH 1337 and AH 1338 respectively, as templates (3.3.3). Size 
and concentration of products where checked through agarose gel electrophoresis (2.3.4) 
(Picture 3.11 – 3.12). 
 plcR upstream and plcR downstream PCR products were observed and were of the 
expected size, ~772 bp and ~891 bp respectively, while spectinomycin- and erythromycin-
resistance cassette PCR products were also observed and of the expected size, ~1200 bp. All 
PCR products were observed as clean and in large amounts.  
 
 
      1                                 2 
 
 papR plcR ykoW 
         1                               2    
  
 
Figure 3.37: Placement of primers for upstream (1) and downstream (2) region of plcR. 
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        1        2         3 
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  






Picture 3.11: Agarose gel electrophoresis of PCR products of spectinomycin- (lane 2) and erythromycin- 
resistance cassettes (lane 3). Size marker lambda/BstE II in lane 1. 
 
                          
 
                          1  2  3 4  5  6  7  8  9  10  11 12 13   14 15 16 17 18 19 20 21 22 
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  






Picture 3.12: Agarose gel electrophoresis of PCR products of upstream (lane 2-13) and downstream (lane 15-
22) fragments of plcR. Size marker lambda/BstE II (lane 1 and 14). 
 
3.3.5 Cloning of plcR upstream into pUC19   
 2 μl (approx. 200 ng DNA) of purified plcR-upstream PCR product (3.3.4) and 10 μl 
(approx. 1 ug DNA) of pUC19 were digested, using KpnI and SacI (2.3.7). Both samples were 
purified (2.3.5) and ligated (2.3.9) at a 1:5 molar ratio (1 ng insert : 5 ng plasmid) over night 
at 16ºC. 5 μl of the ligation mixture was transformed using One Shot Top10 competent cells 
(Invitrogen) (2.3.9). Ampicillin (100μg/ml) was used as a selection marker when cells were 
grown on LB agar plates at 37ºC, over night. Figure 3.38 shows a schematic of the cloning of 
the plcR-upstream fragment into pUC19 through PCR, restriction enzyme digestion, ligation 
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and transformation. Enzyme digestion was performed, as indicated, after PCR amplification 
and purification and allowed for the insertion of the fragment into the MCS of the pUC19 
plasmid. 
            pUC19 
                         2686 bp 
 papR plcR ykoW 




Figure 3.38: Cloning of the plcR upstream region into pUC19 vector. 
 
 After transformation, colonies were checked for presence of insert by plasmid 
purification (2.3.9), restriction enzyme digestion (2.3.7) with KpnI and SacI, and agarose gel 
electrophoresis (2.3.4). Picture 3.13 shows agarose gel electrophoresis analysis of the pUC19 
plasmid containing the plcR-upstream fragment, after the recombinant plasmid has been 
digested with KpnI and SacI. Size of both plasmid and fragment bands were as expected, 2.6 
kb and 772 bp respectively. 
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      1        2 
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  








Picture 3.13: Agarose gel electrophoresis of pUC19_plcRupstream (lane 2) after cloning, purification and 




3.3.6 Cloning of plcR downstream into pUC19_plcRupstream  
 2 μl (approx. 200 ng DNA) of purified plcR-downstream PCR product (3.3.4) and 10 
μl (approx. 1 ug DNA) of recombinant plasmid pUC19_plcRupstream (3.3.5) were digested, 
using BamHI and SalI (2.3.7). Both samples were purified (2.3.5) and ligated (2.3.9) at a 1:5 
molar ratio (1 ng insert : 5 ng plasmid) over night at 16ºC. 5 μl of the ligation mixture was 
transformed using One Shot Top10 competent cells (Invitrogen) (2.3.9). Ampicillin 
(100μg/ml) was used as a selection marker when cells were grown on LB agar plates at 37ºC, 
over night. Figure 3.39 shows a schematic of the cloning of the plcR-downstream fragment 
into pUC19_plcRupstream through PCR, restriction enzyme digestion, ligation and 
transformation. Enzyme digestion was performed, as indicated, after PCR amplification and 




          
pUC19_plcRupstream 
          3458 bp 
 papR plcR ykoW 
plcR-downstream (891 bp) 
plcRupstream 
Figure 3.39: Cloning of the downstream region of plcR into the pUC19_plcRupstream plasmid. 
 
 After transformation, colonies were checked for presence of insert by plasmid 
purification (2.3.9), restriction enzyme digestion (2.3.7) with BamHI and SalI. Picture 3.14 
shows agarose gel electrophoresis (2.3.4) analysis of the pUC19_plcRupstream plasmid 
containing the plcR-downstream fragment, after plasmid has been digested with BamHI and 
SalI. Size of both plasmid and fragment bands were as expected, ~3.4 kb and 891 bp 
respectively. Agarose gel electrophoresis also showed that some cloned did not contain the 
plcRdownstream fragment, indicating that this fragment had not been cloned into the 
pUC19_plcRupstream plasmid. 
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            1   2     3   4   5    6   7   8   9   10 11  12 13 14 
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  







Picture 3.14: Agarose gel electrophoresis of restriction enzyme digestion by BamHI and SalI of 
pUC19_plcRupstream_plcRdownstream (lane 2-5 and 10-13). Size marker lambda/BstE II in lane 1. 
 
3.3.7 Cloning antibiotic resistance cassette into pUC19_plcRupstream_plcRdownstream 
 2 μl (approx. 200 ng DNA) of either spectinomycin or erythromycin resistance 
cassette purified PCR product (3.3.4) and 10 μl (approx. 1 ug DNA) of the 
pUC19_plcRupstream_plcRdownstream construct were digested, using SmaI (2.3.7). Here 
dephosphorylation using alkaline phosphatise (2.3.8) was also necessary to prevent vector 
religation due to the use of only one restriction enzyme. Both samples were purified from gel 
(2.3.5; Picture 3.15) and ligated (2.3.9) at a 1:5 molar ratio (1 ng insert : 5 ng plasmid) over 
night at 16ºC. 5 μl of the ligation mixture was transformed using One Shot Top10 competent 
cells (Invitrogen) (2.3.9). Ampicillin (100μg/ml) was used as a selection marker when cells 
were grown on LB agar plates at 37ºC, over night. Figure 3.40 shows a schematic of the 
cloning of the spectinomycin resistance cassette into pUC19_plcRupstream_plcRdownstream 
construct through PCR, restriction enzyme digestion, ligation and transformation. Enzyme 
digestion was performed, as indicated, after PCR amplification and purification, and allowed 
for the insertion of the antibiotic resistance cassette into the MCS of the 
pUC19_plcRupstream_plcRdownstream plasmid. 
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           pUC19_ 
plcRupstream_plcRdownstream 
                         4349 bp 
plcRdownstream plcRupstream 
Spectinomycin- or Erythromycin-resistance cassette 
 
Figure 3.40: Cloning of resistance cassette (spectinomycin/erythromycin) into 
pUC19_plcRupstream_plcRdownstream. 
  
      1                         2                        3 
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  







Picture 3.15: Agarose gel electrophoresis of restriction enzyme digestion of 
pUC19_plcRupstream_plcRdownstream_spectinomycin construct with Sma I (lane 2) and restriction enzyme 
digest of pUC19_plcRupstream_plcRdownstream_spectinomycin construct with Sma I (not dephosphorylated) 
(lane 3). Size marker lambda/BstE II in lane 1. 
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After transformation, colonies were checked for presence of insert by plasmid 
purification (2.3.9), restriction enzyme digestion (2.3.7) with EcoRI and HindIII and agarose 
gel electrophoresis (2.3.4). This restriction enzyme digestion was preformed specifically to 
verify that the MCS contained the entire plcRupstream fragment, the entire plcRdownstream 
fragment and the entire antibiotic resistance cassette. This would also be the same restriction 
enzyme digestion performed to clone the construct into pAT113.  Picture 3.16 – 3.17 shows 
agarose gel electrophoresis analysis of the pUC19 _plcRupstream _plcRdownstream- 
_spectinomycin construct, after the recombinant plasmid had been digested with EcoRI and 
HindIII. The size of the bands of both the plasmid and the fragment were not as expected in 
any of the clones analyzed (expected sizes were ~2.6 kb for the plasmid and ~2.8 bp for the 
fragment) (Picture 3.16 – 3.17). These agarose gels show through analysis of the band sizes 
that this step of cloning did not work and that the antibiotic resistance cassette was not cloned 




  1        2         3         4        5        6         7        8 
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  







Picture 3.16: Agarose gel electrophoresis of restriction enzyme digestion of 
pUC19_plcRupstream_plcRdownstream_spectinomycin (lane 3-8) with EcoRI and HindIII. Size marker 
lambda/BstE II in lane 1. 
 




1         2          3       4          5        6        7         8  
 
8,454 –  
7,242 –  
6,369 –  
5,686 –  
4,822 –  
4,324 –  







Picture 3.17: Agarose gel electrophoresis of restriction enzyme digestion of 
pUC19_plcRupstream_plcRdownstream_spectinomycin (lane 3-8) with EcoRI and HindIII. Size marker 
lambda/BstE II in lane 1. 
 
 A total of 24 colonies (only 12 colonies checked showed here) were checked for the 
presence of the inserted antibiotic resistance cassette, but none of the colonies gave expected 
band sizes through agarose gel electrophoresis analysis. Samples 7 (Picture 3.16) and 4 
(Picture 3.17) were sent to sequencing for verification of agarose gel electrophoresis analysis. 
 
3.4 Sequence analysis 
3.4.1 Sequence analysis of resistance cassettes 
 Sequencing and sequence analysis of the antibiotic resistance cassettes, used in the 
construction of the plcR knock-out construct, was preformed to confirm the sequence of the 
cassettes present in our clones (AH 1337 and AH 1363), to confirm that the sequence was 
correct and for comparison when sequencing the clones made in this thesis. Sequencing of 
pUC19_spectionmycin and pUC19_erythromycin (6.2.2) was preformed by GATC 
(Germany), using M13F and M13R primers (Figure 6.29 – 6.30). Sequence analysis showed 




3.4.2 Sequence analysis of constructs made for plcR knock-out  
 Sequencing and sequence analysis of the constructs made for the plcR knock-out 
procedure was performed to confirm the sequences of the constructs. All constructs (3.3.5 – 
3.3.7) were sequenced using M13forward and M13reverse primers (Figure 6.31 – 6.33). 
 During primer design and construct initiation the coordinates of the plcR locus in B. 
cereus ATCC 10987 (AE017197) were recorded as being from 5060487 to 5061344. When 
sequences inserted into pUC19 where compared to this sequence, the construct only 
containing the plcRupstream region gave a match to B. cereus ATCC 10987 at 5061978 to 
5061344, indicating that the PlcR upstream region was correctly cloned. The 
pUC19_plcRupstream_plcRdownstream construct gave a match to B. cereus ATCC 10987 at 
5061978 to 5061344 and at 5060472 to 5060058, indicating that both the upstream and the 
downstream region was correctly cloned. 
Further sequence analysis was done using Align (bl2seq) to compare the sequenced 
constructs against the known sequences of the upstream and downstream sequences of the 
plcR locus. These results gave an almost perfect match, indicating that the sequence inserted 
into the pUC19 vector is correct and matches the sequence present in B. cereus ATCC 10987 













Figure 3.42: pUC19_plcRupstream_plcRdownstream construct aligned with known plcR downstream sequence, 
using Align. 
 
 However, when sequence analysis of the pUC19_plcRupstream_plcRdownstream- 
_spectinomycin and pUC19_plcRupstream_plcRdownstream_erythromycin constructs were 
preformed, the presence of the plcR upstream region and the plcR downstream region could 
not be detected in its entire size using blastn or bl2seq and only the presence of the entire 
resistance cassette was seen to be present in the construct (Figure 3.43). The construct 
containing the erythromycin cassette showed no sequence similarities with any plcR locus 
sequences and showed only the presence of the entire erythromycin resistance cassette, while 
the construct containing the spectinomycin cassette showed some similarities to the plcR 
locus, but sequences where very short (~38 bp) and not seen to be anywhere close to original 




Figure 3.43: pUC19_plcRupstream_plcRdownstream_spectinomycin aligned with the known sequence of the 
spectinomycin cassette, using Align. 
  
 This indicated, through sequence analysis, that the constructs after cloning of the 
antibiotic resistance cassette, contained the antibiotic resistance cassette (in the case of the 
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erythromycin cassette construct), but unexpectedly, only small fragments of the plcR flan


























4 DISCUSSION AND CONCLUSIONS 
 
4.1 The biof
The formation of biofilm by bacteria is often seen to happen, is thought to be an 







.2.1 Colony morphology  
 morphology could be indicative of 
the tendency for growth on surfaces. For the B. cereus group bacteria the morphology of the 
ilm conundrum 
 
important part of some infections in
least partly responsible for the ability of some bacteria to live in natural environments no
suitable for normal growth (O’Toole et al., 2000). Still very much is unknown of the 
processes involved, and the mechanisms behind will be discussed and studied by 
microbiologists for many years to come. The ability of certain bacterial strains to prod
biofilm, the reason why they have this ability and the mechanism behind biofilm f
certainly extends beyond the scope of this thesis. However, this thesis does present an 
effective method for biofilm formation investigation that allows screening of a high number 
of strains with many parallels and does give indicative results of biofilm formation among the 
Bacillus cereus group of bacteria. This method for biofilm screening does of course not reflec
the natural conditions of the source of origin of any of these strains, but the method gives a 
quick and reliable way to obtain results, which can initiate further studies into the ability of 
one particular strain to form biofilm. The setup for the biofilm screening procedure was don
in collaboration with Dr. Michel Gohar at INRA, France. This has produced a method which 
is easily reproducible between laboratories and between groups studying the Bacillus cereus 
group bacteria and their ability to form biofilm. 
 
4.2 Bacterial growth during biofilm scr
4
 We wished to investigate whether bacterial colony
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our reference strains and the standard growth for 
the selected strains (3.1.2 and 3.1.3) clearly indicate that the different strains grew with almost 
ately at the same time (3 hours), under 
colonies and from shiny to mate surfaced, but mostly differ in the size of the colony. As 
observed, some strains, e.g. AH 183 and AH 1031, form larger colonies with a somewhat 
jagged outline, while other strains, e.g. AH 75 and AH 1248, form small colonies with s
outline. These differences did, however, not seem to have any affect of a strains ability to
form biofilm. While AH 183 is a biofilm-negative strain, AH 1031 is a strong biofilm form
and while AH 75 is a biofilm forming strain, AH 1248 is biofilm negative. Colony 
morphology could therefore be disregarded as a fundamental pathway for biofilm formatio
clearly indicating that there are other more important factors involved in the formation of 
biofilm. 
AH 884 was the only strain, which produced a colony morphology different from wha
generally observed. This strain gave “slimy” collection of colonies on the plate and single 
colonies w
spitalet, Oslo, Norway), but due to the different colony morphology and the high level 
of biofilm formation ability, the strain was further investigated. Using universal 16S rRNA
primers the species classification was determined (performed by Erlendur Helgason
Veterinary Institute, Norway). The results showed that AH 884 actually is a Bacillus 
licheniformis strain, which can explain the unusual colony morphology and strong ability to 
form biofilm, as B. licheniformis strains have been observed to form biofilm (Ameur, et al., 
2005).  
 
4.2.2 Bacterial growth over time 
 The standard growth curve for the f
identical speed and reach exponential growth approxim
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the growth conditions used here. No difference between strains forming biofilm and those tha
do not could be observed. This time point (3 hours) was therefore used throughout the study, 
as the time point for extraction of samples for use during growth in microtiter plates. 
 
4.3 Biofilm screening 
4.3.1 Testing and optimisation of the biofilm screening system 
t 
Four strains were picked to establish the test system for biofilm screening. Bacillus 
), Bacillus cereus ATCC 14579 (AH183), Bacillus cereus AH 









cereus ATCC 10987 (AH75
812 and Bacillus thuringensis 407 (AH1031) were used as test stra
AH 1031 were known biofilm-positive strains and AH 183 and AH 812 were known biofilm
negative strains. This allowed the establishment of a screening system, based on a method 
used at INRA, France (Michel Gohar, personal communication). As indicated in section 3.2 
neither the amount of culture in each well of the microtiter plate, nor the position of the 
cultures on the plate, were observed to affect the strains ability to form biofilm. However, t
shape of the microtiter plate wells, the presence of moisture (H2O soaked filter paper), and the
type of medium in which the strains where grown had some effect. In the final protocol, 
biofilm screening was done in microtiter plates with round bottomed wells (not flat bottomed) 
and a lid, in the presence of a moist filter paper, Furthermore, strains were incubated in 
bactopeptone medium when inoculated on the microtiter plates. Due to the fact that a 
somewhat high level of background signal was observed with “crude” crystal violet, sterile 
filtration of the crystal violet solution was included in the protocol to remove crystals no
dissolved. This did help to remove some background signal, but, as indicated, the unsp
staining by crystal violet in some wells was not completely removed. 
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4.3.2 Crystal violet staining – technical consideration 
 This biofilm screening procedure is based on the crystal violet staining of cells 
ttached to the well after washing with PBS. We therefore investigated whether the amount of 
rystal violet absorbed by cells at 590 nm was directly linked to the number of bacterial cells 
rially diluted and stained with the 
ame a er 
 
lls 
interface were interpreted as cells that had 
formed
 
 to the PVC surface of the wells. This ring was clearly present for all 
ositiv
s 





in the culture. To check this, three strains were picked, se
s mount of crystal violet (2.2.4; 3.1.4). The final result clearly indicated that a high
dilution of bacterial cells produced a lower absorbance of crystal violet, as expected, although 
not observing complete linearity for all strains. 
The result of the serial dilution test confirmed the basis for the screening method, i.e.
that the amount of crystal violet absorbed shows correlation with the amount of bacterial ce
present. The number of bacterial cells present, after washing the wells with PBS, and forming 
the characteristic ring structure in the liquid-air 
 a biofilm.    
 As mentioned above, the use of crystal violet also allows for direct visualisation of 
biofilm formation in the well (picture 3.5). This picture clearly shows that the crystal violet 
binds in a ring formation around the air-liquid phase of the wells and that this ring is actual
bacterial cells bound
p e strains, although in somewhat different thickness.  
 The use of crystal violet did however produce a somewhat high level of background 
signal and a relatively high standard deviation for samples. The level of background signal i
clearly observed in the wells incubated with pure bactopeptone medium only (no bacteria 
inoculated); a weak crystal violet ring may be observed and 
level of colour when solubilised. The somewhat high standard deviation, i.e. the variability in
absorbance between wells with the same strain incubated, was also a result of crystal violet 
binding unspecifically to the PVC in the well during staining, even when crystal violet was
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sterile filtered. This could be observed by the presence of crystals of crystal violet spread 
around, not forming a ring, in the wells. Wells with crystal violet still present, i.e. unable to be 
washed away, for strains that were clearly biofilm-negative, i.e. did not form the ring 
structure, in some cases produced high level of absorbance, and large difference in absorban
between wells, and thus a high standard deviation. This was often observed in single wells
the 16 parallels wells that were inoculated for each strain, and since all wells were included in 
the analysis, contributed to the observed large standard deviations. 
The numerical results following crystal violet staining were not used as the single 
criterium for biofilm formation. We decided on introducing a second criterium, the presence 
of a characteristic “ring” formation in the well (in the liquid/air interface), for comparison 
with the numerical results. High average absorbance values and the 
ce 
 of 
visualisation of the “ring” 
were in  
, 
ed bacterial cells. Biofilm formation has been observed for a 
rge collection of bacteria, e.g. Pseudomonas aeruginosa, Escherichia coli, Vibrio cholerae,  
coccus aureus, Bacillus subtilis and Bacillus cereus and 
is obse
1 
 combination considered to give this method for biofilm screening the accuracy and
specificity that is required.  
 
4.3.3 Biofilm screening 
An excellent model system for studying bacterial diversity is the formation of biofilm
a formation of surface-attach
la
Staphylococcus epidermidis, Staphylo
rved to play a key role in the production and degradation of organic matter (Dahlberg 
et al., 1997; Watnick et al., 1999; Yildiz et al., 1999). Bacterial cells are also thought to 
experience a certain degree of shelter and homeostasis when residing within a biofilm 
(Madigan et al., 1997).  
 In this study the aim was to establish a method for screening B. cereus group of 
bacteria for their ability to form biofilm. Biofilm screening was performed on a total of 8
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strains from the Bacillus cereus group of bacteria. The 81 strains screened were selecte
a phylogenetic tree const
d from 
ructed by multilocus enzyme electrophoresis ( MLEE) (Helgason et 
l., unp ns a ublished) (Figure 4.1) and carefully chosen such that the 81 strains included strai
from a variety of sources, and were spread throughout the tree. Strains screened for biofilm 
formation (indicated with horizontal line) and strains positive for biofilm formation (indicated 




In total, 7 strains were characterized as biofilm-positive and 74 strains as biofilm-
negative, i.e. the frequency of positive strains was ~9%. This showed that only a limited 
number of strains from the B. cereus group bacteria screened in this thesis, had the ability to 
form biofilm. This percentage of biofilm positive strains was not far from expected, based on 
earlier results obtained by Michel Gohar, using a different set of strains (14% biofilm positive 
strains). The number of strains screened and the random selection of strains screened for this 
thesis could be the reason for the difference in frequency, but both results indicate that biofilm 
formation may not be a very frequent feature in the B. cereus group of bacteria. 
 
The following strains were characterized as biofilm formers: 
 
• Bacillus cereus ATCC 10987 (AH 75), isolated from spoiled cheese (dairy) 
• Bacillus cereus ATCC 4342 (AH 226), isolated from milk 
• Bacillus cereus 1230 (AH 405), dairy isolate 
• Bacillus cereus vet-11 (AH 604), dairy isolate 
• Bacillus cereus (AH 815), clinical isolate, periodontitis 
• Bacillus licheniformis (AH 884), clinical isolate, blood culture 
• Bacillus thuringensis Bt 407 (AH 1031), soil isolate 
 
 and These 7 strains were isolated from dairy products, from human infections in blood
mouth (gum) and from soil, and indicate that the ability to form biofilm is not strictly linked 
to strain origin. These strains were also widely spread in phylogenetic trees (constructed by 
MLEE/MLST, Helgason, et al., 2003), showing that biofilm formation is not a clonal property 
in the B. cereus group.  
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Some similarities are however seen, when looking at the origin of the strains and 
realising that six out of seven of the biofilm-positive strains were isolated outside of their 
atural environment, i.e. they are isolated from places not considered to be natural habitats of 
ensen et al., 2003). This can be 
indicative that the ability to form biofilm is a survival mechanism and not a direct virulence 
factor prod e l 
cavity or re rr
Vic sarily correlate with respect to 
biofilm for t tal infections were screened and 
only 1 stra een with AH 75, AH 
405 and AH 0 reened and 
only 3 wer e y 2 out of a total of 25 
trains screened were biofilm-positive and only 1 out of 8 B. thuringensis strains showed 
biofilm
of 
 biofilm formation by the B. cereus group bacteria is unique with 
referen  
etic pathways that control biofilm behavior (O’Toole 
n
B. cereus group bacteria, which is soil and/or the insect gut (J
uc d by the bacteria, such as allowing the bacteria to colonise the human gut, ora
fe ing antibiotic resistance. 
e versa, strains from the same source did not neces
ma ion. A total of 11 strains isolated from periodon
in was seen to be biofilm-positive (AH 815). The same was s
 6 4, which are all dairy strains. A total of 18 dairy strains were sc
e s en to be biofilm-positive. For the clinical isolates, onl
s
 formation, which again indicates that no specific correlation between isolation source 
and the ability for the strain to form biofilm was observed for B. cereus group bacteria. 
There could not be found any large scale biofilm screening, preformed on one group 
bacterial species, for comparison with results from this study. Therefore could we not draw 
any conclusions whether
ce to frequency of biofilm formation or correlation between source of isolation and
ability to form biofilm. 
 
4.4 Knock-out construction of plcR 
4.4.1 Biofilm formation and genetics 
Biofilm formation involves a large degree of gene regulation, which is evident from 
the fact that organisms have multiple gen
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mation of biofilm. The knock-out construction was initiated to 
bserve if the deletion of PlcR would influence the ability of B. cereus ATCC 10987 to form 
 locus knock-out in B. cereus ATCC 10987, was to 
produce flanking fragm
000). Up-regulation of genes has been seen to occur during biofilm formation, such a
the up-regulation of adhesion molecule genes in V. cholerae (Yildiz et al., 1999) and up-
regulation of pili-mediated movement in P. aeruginosa (Wall et al., 1999), and the number of
genes thought to be involved in biofilm formation is high and has been observed to be 
constantly extended for each year of research. Within the scope of this thesis, the emphasis 
has been placed on the putative role of the plcR gene, a pleiotropic regulator of extracellular 
virulence factors in B. cereus ATCC 10987. PlcR was selected due to preliminary results 
indicating that PlcR could be involved in biofilm formation in B. thuringensis 407 and th
tant of B. cereus ATCC 10987 could induce biofilm formation in strains otherwise not 
able to form biofilm (Michel Gohar, personal communication). 
The construction of a knock-out construct of plcR was initiated to investigate a 
possible role of PlcR, a pleitropic regulator of extracellular virulence factors in the B. cereu
group bacteria, in the for
o
biofilm. 
The strategy used to produce a plcR
ents of the locus by PCR, and clone these fragments into a vector, with 
an antibiotic resistance cassette cloned between the PlcR flanking fragments, as a selection 
marker. The upstream- and downstream-fragments of the plcR locus and the antibiotic 
resistance cassette was to be first cloned into pUC19 (smaller and easier vector to work with 
than pAT113). The entire insert was then to be cloned into pAT113 using E. coli as host, 





4.4.2 Cloning of plcR flanking regions 
 From agarose gel electrophoresis analysis and the sequence analysis of the clones, the 
plcR upstream and downstream regions were successfully cloned into pUC19, and correctly 
inserted






ifficulties arise during the ligation or the transformation of the antibiotic resistance cassette 
to the clone. Unfortunately this left the final construct useless for knock-out procedure of 
e plcR locus in B. cereus ATCC 10987 and for future work, the final cloning step must be 
hich plcR upstream and downstream regions are 
orrect
A method for biofilm screening of Bacillus cereus group bacteria was through this 
the limits are only the number of strains available to 
screen. Further screening, of the more than 200 strains left in our collection, could give 
 (oriented) into the plasmid. 
 
4.4.3 Cloning of resistance cassettes 
 Agarose gel electrophoresis analysis did not show a band of the expected size (~2.9 
kb) and th
ct was unsuccessful. Sequence analysis showed that the upstream and downstream 
regions of plcR were absent in the constructs containing the resistance cassettes. During the 
insertion of the resistance cassettes, the initial insertions of the construct have seemingly bee
disturbed, digested away or degraded, leaving only partial or no remaining elements of 
upstream and downstream fragments. Only present is the complete resistance cassette, which 
produced false positive results during the cloning procedure. As seen when digestion with




repeated, using preliminary construct in w
c ly inserted. 
 
4.5 Further studies 
 
work established in the laboratory and 
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additional knowledge of any correlation between strains and their source of origin. The 
screening is cheap, effective and gives results that are reliable, although perhaps somewhat 
crude. Efforts could be made to establish an alternative method for second-round screening
strains positive in the microtiter assay, such as a glass wool based approach (Oosthiuzen et 
al., 2001). This would allow a high number of strains to be screened in round one and a lower 
number of strains needed to screen by more elaborate assays. 
 Future work on the knock-out construct will include finalizing the cloning of the 
spectinomycin cassette and moving the whole construct into pAT113, to be used to knock-o
the plcR locus in B. cereus ATCC 10987. This will entail going back to the construct 
containing the upstream and downstream regions of the plcR locus and proceed with the 
insertion of the spectinomycin or the erythromycin resistance cassette once more. Due to the
obvious difficulties during the construction, additional control steps will also need to be 





formation and transformation efficiency calculation. This would allow the 
onstruction of the ∆plcR construct and the investigation of the speculated role of PlcR in 







∆ strain. This work will also be linked with the molecular studies of a unique 
exopolysaccharide (EX-1) locus from B. cereus ATCC 10987 (Rasko et al., 2004) performe
in our laboratory (Christine Jensen, master thesis) and by Michel Gohar, INRA, France. 
Mutational deletion of EX-1 in B. thuringensis 407 has shown that the locus is involved 
motility and in biofilm formation (Michel Gohar, unpublished). 
 In combination, biofilm screening and genetic studies, will allow for a deeper insight 
into the genetics involved in biofilm formation in B. cereus group bacteria and could result i
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6.1 Biofilm formation 
 Biofilm screening graphs with raw data r, which background signal has not been 
































(background signal from negative control not deducted), with standard deviation from 16 parallels included. 
 
































Figure 6.2: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
































Figure 6.3: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 































Figure 6.4: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 































Figure 6.5: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 

































Figure 6.6: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 






























Figure 6.7: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 
































Figure 6.8: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 
































Figure 6.9: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 































Figure 6.10: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 































Figure 6.11: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 


































Figure 6.12: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 





































Figure 6.13: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 










































Figure 6.14: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 






































Figure 6.15: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 





































Figure 6.16: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 






































Figure 6.17: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 







































Figure 6.18: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 



































Figure 6.19: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 






































Figure 6.20: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 






































Figure 6.21: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 







































Figure 6.22: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 






































Figure 6.23: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 








































Figure 6.24: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 






































Figure 6.25: Biofilm formation as measured by crystal violet absorbance after 24 hours of incubation 







































Figure 6.26: Biofilm formation as measured by crystal violet absorbance after 48 hours of incubation 






































Figure 6.27: Biofilm formation as measured by crystal violet absorbance after 72 hours of incubation 
(background signal from negative control not deducted), with standard deviation from 16 parallels included. 
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6.2 
6.2.1 pUC19 cloning vector 
Construction of a plcR knock-out of Bacillus cereus ATCC 10987 
 



















































































































































































Figure 6.33: Sequence of pUC19_plcRupstream_plcRdownstream_spectinomycin clone insert. Sequence starts 
as read from M13forward primer. 
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